An individual may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, the individual may have surgery or a disability that impairs mobility. In another example, the individual may have restricted travel conditions such as those experienced by pilots, drivers, and workers in hazardous areas. Additionally, fluid collection from the individual may be needed for monitoring purposes or clinical testing.
Bed pans and urinary catheters, such as a Foley catheter, may be used to address some of these circumstances. However, bed pans and urinary catheters have several problems associated therewith. For example, bed pans may be prone to discomfort, spills, and other hygiene issues. Urinary catheters may be uncomfortable, painful, and may cause urinary tract infections.
Thus, users and manufacturers of fluid collection devices continue to seek new and improved devices, systems, and methods to collect urine.
Embodiments disclosed herein are related to fluid collection devices, and related systems and methods. In an embodiment, a fluid collection system includes a fluid collection device having a fluid impermeable barrier and a fluid permeable body. The fluid impermeable barrier includes a distal end region, a proximal end region, a front side, and a back side. The fluid impermeable barrier defines an opening on the front side, one or more apertures on the back side distal to the opening and positioned between the distal end region and the proximal end region, and a chamber within the fluid collection device. The fluid permeable body is positioned within the chamber and extends across at least a portion of the opening.
In an embodiment, a method of collecting fluid includes positioning an opening defined by a fluid impermeable barrier of a fluid collection device at least proximate to a urethral opening of a user with a fluid permeable body extending at least partially across the opening being positioned at least proximate to the urethral opening. The method also includes collecting fluid discharged by the user in a chamber of the fluid impermeable barrier. The method also includes passing the fluid in the chamber through one or more apertures on a back side of the fluid impermeable barrier distal to the opening and positioned between a distal end region and a proximal end region of the fluid impermeable barrier.
Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.
The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.
Embodiments disclosed herein are related to fluid collection devices having one or more openings on a back side of the fluid collection device, and related systems and methods. In at least one, some, or all embodiments of fluid collection devices described herein, the fluid collection devices includes at least one substantially planar end region, thereby providing a more flat fluid collection device that may provide a more comfortable use of the fluid collection device by patients while sitting. In some embodiments, the fluid collection devices may include a spine (e.g., support member) included in the fluid collection device for approximately half of a longitudinal length of the fluid collection device. In at least one, some, or all embodiments of fluid collection devices described herein, the spine may allow the fluid collection device to form and retain a desired shape with a portion of the fluid collection device positioned against a urethral opening of the user and a portion of the fluid collection device positioned underneath the user.
The fluid collection devices may include a back side that is permeable and/or includes one or more apertures (e.g. holes or openings) sized and positioned to allow fluid to pass through the backside. In some embodiments, the fluid collection devices may include a fluid impermeable collection bag secured to the fluid collection device and positioned to receive urine discharged in the fluid collection device through the one or more apertures on the back side of the fluid collection device. In use, once the chamber defined at least partially by the fluid impermeable is filled to at least partial capacity, fluid may flow from the chamber, through the one or more apertures, and into an interior region of the fluid impermeable collection bag, thereby giving the fluid collection device more capacity for fluid collection. The fluid impermeable collection bag may be sized and dimensioned to be positioned between legs of the user and may be flexible to be positioned in whatever space may be available between the legs of the user. Fluid collection devices described herein may be of particular use to individuals sitting in a wheelchair. The fluid impermeable collection bag may be supported on the seat of the chair between the legs of the user. The interior region of the fluid impermeable collection bag may include at least one of an odor elimination agent (such as vitamin C) or a solidifying agent (such as gel beads).
In at least one, some, or all embodiments of fluid collection devices described herein, the fluid collection device having a fluid impermeable collection bag secured to the fluid impermeable barrier may eliminate the need to store and utilize a pump that draws fluid from the fluid collection device. In at least one, some, or all embodiments of fluid collection device described herein, the fluid impermeable collection bag allows individuals having incontinence issues that result in small, gradual fluid discharge throughout the day to use the fluid collection device.
The fluid impermeable barrier 102 may be elongated and may include a substantially flat or planar edge 103a, 105a or rim at one or more of the distal end region 105 or the proximal end region 103. The fluid impermeable barrier 102 may include a substantially oval or half-oval front profile, or other suitable profile. In some embodiments, the fluid impermeable barrier 102 and/or the fluid permeable body 110 may be contoured to protrude or arc relative to the substantially flat or planar edge 103a, 105a, giving the fluid collection device 100 a “duck-bill” shape. This shape of the fluid collection device 100 may be more comfortable to a user while the user is sitting. The substantially flat edge 103a, 105a, for example, may be comfortable for the user when positioned under the user. In some embodiments, the fluid impermeable barrier 102 and the fluid permeable body may be substantially cylindrical.
The opening 106 is formed in and extends longitudinally through the front side 109 the fluid impermeable barrier 102, thereby enabling fluids to enter the chamber 104 from outside of the fluid collection device 100. The opening 106 may be configured to be positioned at least proximate to (e.g., adjacent to) the opening of a female urethra or over the opening of a urethra of a male having a buried penis. The opening 106 may exhibit an elongated shape that is configured to extend from a first location below the urethral opening (e.g., at or near the anus or the vaginal opening) to a second location above the urethral opening (e.g., at or near the clitoris or the pubic hair). The opening 106 may exhibit an elongated shape since the space between the legs of a female is relatively small when the legs of the female are closed, thereby only permitting the flow of the fluids along a path that corresponds to the elongated shape of the opening 106. For example, the opening may extend longitudinally along the fluid impermeable barrier. The opening 106 in the fluid impermeable barrier 102 may exhibit a width that is measured transverse to the longitudinal direction and may be at least about 10% of the circumference of the fluid collection device 100, such as about 25% to about 50%, about 40% to about 60%, about 50% to about 75%, about 65% to about 85%, or about 75% to about 100% of the circumference of the fluid collection device 100. The opening 106 may exhibit a width that is greater than 50% of the circumference of the fluid collection device 100 since the vacuum (e.g., suction) through the conduit 108 pulls the fluid into the conduit 108. In some embodiments, the opening 106 may be vertically oriented (e.g., having a major axis parallel to the longitudinal axis of the device 100). In some embodiments, (not shown), the opening 106 may be horizontally oriented (e.g., having a major axis perpendicular to the longitudinal axis of the device 100). In some embodiments, the inward border or edge of the fluid impermeable barrier 102 defines the opening 106. The edge may include two opposing arced portions, the arc portions following the outer circumference or periphery of the fluid impermeable barrier 102. The region of the back side 107 defining the one or more apertures 122 may be fluid impermeable and may include the same or different material as the fluid impermeable barrier 102.
The fluid impermeable barrier 102 may also temporarily store the fluids in the chamber 104. For example, the fluid impermeable barrier 102 may be formed of any suitable fluid impermeable materials, such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, a polycarbonate, etc.), polyurethane films, thermoplastic elastomer (TPE), rubber, thermoplastic polyurethane, another suitable material, or combinations thereof. The fluid impermeable barrier 102 is flexible, thereby enabling the fluid collection device 100 to bend or curve when positioned against the body of a wearer. Example fluid impermeable barriers may include, but are not limited to, a fluid impermeable barrier including at least one of Versaflex CL 2000X TPE, Dynaflex G6713 TPE, or Silpuran 6000/05 A/B silicone. In an embodiment, the fluid impermeable barrier 102 may be air permeable. In such an embodiment, the fluid impermeable barrier 102 may be formed of a hydrophobic material that defines a plurality of pores. In an embodiment, one or more portions of at least the outer surface of the fluid impermeable barrier 102 may be formed from a soft and/or smooth material, thereby reducing chaffing.
Turning to
The region of the back side 107 defining the plurality of apertures 122 may extend at least partially between the proximal end region 103 and the distal end region 105. For example the plurality of apertures 122 may be positioned from the proximal end region 103 to at least about one-quarter of a longitudinal length to the distal end region 105, at least about one-third of the longitudinal length to the distal end region 105, at least about one-half of the longitudinal length to the distal end region 105, at least about two-thirds of the longitudinal length to the distal end region 105, at least about three-quarters of the longitudinal length to the distal end region 105, about one-quarter of the longitudinal length to the distal end region 105, about one-third of the longitudinal length to the distal end region 105, about one-half of the longitudinal length to the distal end region 105, about two-thirds of the longitudinal length to the distal end region 105, about three-quarters of the longitudinal length to the distal end region 105, or substantially all of the longitudinal length to the distal end region 105. The plurality of apertures 122 may be positioned to extend across a portion of a lateral width of the back side 107, such as about one-eighth, about one-quarter, about one-third, about one-half, about two-thirds, about three-quarters, or substantially all of a lateral width of the back side 107.
The fluid impermeable collection bag 120 may be secured or securable to the fluid impermeable barrier 102 to cover the plurality of apertures 122. The fluid impermeable collection bag 120 may include any of the materials described above in relation to the fluid impermeable barrier 102. In some embodiments, the fluid impermeable collection bag 120 may include a fluid impermeable film that imparts the bag-like characteristic of the fluid impermeable collection bag 120. In some embodiments, the fluid impermeable collection bag 120 includes one or more of polyvinyl chloride and phthalates, polypropylene, ethylene vinyl acetate, or combinations thereof. The fluid impermeable collection bag 120 may be flexible to form whatever space is available between legs of the user. In some embodiments, the fluid impermeable collection bag 120 may include any suitable flexible or rigid container that is secured or securable to the fluid impermeable barrier 102. In some embodiments, the fluid impermeable collection bag 120 is fixedly secured to the fluid impermeable barrier 102. In some embodiments, the fluid impermeable collection bag 120 is selectively and/or removably securable to the fluid impermeable barrier 102, and the fluid impermeable barrier 102 may be re-usable with a different or new fluid impermeable collection bag 120 after a previous fluid impermeable collection bag 120 has been use (e.g., at least partially filled with fluid).
As previously discussed, the fluid collection device 100 also includes the fluid permeable body 110 positioned within the chamber 104 and extending at least partially across the opening 106 and at least partially between the distal end region 105 and the proximal end region 103. The fluid permeable body 110 may be shaped generally complementary to the shape of the chamber 104 of the fluid impermeable barrier 102. In some embodiments, the fluid permeable body 110 fills substantially all of the chamber 104.
The fluid permeable body 110 can be configured to wick and/or allow transport of fluid away from the opening 106 towards the plurality of apertures 122. The fluid permeable body 110 can include any material that can wick and/or allow transport of the fluid. The permeable properties referred to herein can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” Such “wicking” or other physical properties may exclude absorption into the fluid permeable body 110, such as not include adsorption of the bodily fluids into the fluid permeable body 110. Put another way, substantially no absorption or solubility of the bodily fluids into the material may take place after the material is exposed to the bodily fluids and removed from the bodily fluids for a time. While no absorption or solubility is desired, the term “substantially no absorption” may allow for nominal amounts of absorption and/or solubility of the bodily fluids into the fluid permeable body 110 (e.g., absorbency), such as less than about 30 wt % of the dry weight of the fluid permeable body 110, less than about 20 wt %, less than about 10 wt %, less than about 7 wt %, less than about 5 wt %, less than about 3 wt %, less than about 2 wt %, less than about 1 wt %, or less than about 0.5 wt % of the dry weight of the fluid permeable body 110. In an embodiment, the fluid permeable body 110 may include at least one absorbent or adsorbent material.
The fluid permeable body 110 can include a one-way fluid movement fabric. As such, the fluid permeable body 110 can remove fluid from the area around the penis, thereby leaving the area and urethra dry. The fluid permeable body 110 can enable the fluid to flow generally towards the plurality of apertures 122. The fluid permeable body 110 can include a porous or fibrous material, such as hydrophilic polyolefin. In some embodiments, the fluid permeable body 110 consists of or consists essentially of a porous or fibrous material, such as hydrophilic polyolefin. Examples of polyolefin that can be used in the fluid permeable body 110 include, but are not limited to, polyethylene, polypropylene, polyisobutylene, ethylene propylene rubber, ethylene propylene diene monomer, or combinations thereof. Moreover, the fluid permeable body 110 can be manufactured according to various manufacturing methods, such as molding, extrusion, or sintering. The fluid permeable body 110 can include varying densities or dimensions.
In some embodiments, the fluid permeable body 110 can include two or more layers of fluid permeable materials. For example, the fluid permeable body 110 can include a fluid permeable membrane covering or wrapped around a fluid permeable support, with both the fluid permeable membrane and the fluid permeable support being disposed in the chamber 104. The fluid permeable membrane can cover or extend across at least a portion (e.g., all) of at least the side of the fluid permeable support facing the penis of the user. The fluid permeable membrane and the fluid permeable support can be configured to wick any fluid away from the opening 106, thereby preventing the fluid from escaping the chamber 104 through the opening 106 and promoting removal of the fluid from the chamber 104 through the plurality of apertures 122. The permeable properties referred to herein can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.”
The fluid permeable membrane and the fluid permeable support also can wick and/or allow transport of the fluid generally towards the plurality of apertures 122. The fluid permeable membrane can include any material that can wick the fluid. For example, the fluid permeable membrane can include fabric, such as a gauze (e.g., a silk, linen, polymer based materials such as polyester, or cotton gauze), nylon (such as a spun nylon fibers), another soft fabric (e.g., jersey knit fabric or the like), or another smooth fabric (e.g., rayon, satin, or the like). Forming the fluid permeable membrane from gauze, soft fabric, and/or smooth fabric can reduce chaffing caused by the fluid collection device 100. Other embodiments of fluid permeable membranes and fluid permeable supports are disclosed in U.S. patent application Ser. No. 15/612,325 filed on Jun. 2, 2017; U.S. patent application Ser. No. 15/260,103 filed on Sep. 8, 2016; U.S. patent application Ser. No. 15/611,587 filed on Jun. 1, 2017; PCT Patent Application No. PCT/US19/29608, filed on Apr. 29, 2019, the disclosure of each of which is incorporated herein, in its entirety, by this reference. In many embodiments, the fluid permeable body 110 includes a fluid permeable support including a porous spun nylon fiber structure and a fluid permeable wicking membrane including gauze at least partially enclosing the spun nylon fiber structure. For example, the fluid permeable body 110 may include a gauze or other wicking fabric positioned to contact the skin of the user through the opening 106. In some embodiments, the gauze or other wicking fabric is wrapped around a body of spun nylon fibers material and/or covering both sides of a substantially planar spun nylon fibers material. In some embodiments, the gauze or other wicking fabric covers the side of substantially planar spun nylon fibers material that is oriented towards the skin of the user.
In some embodiments, the fluid collection device 100 also may include an additional fluid permeable body 130 positioned within the interior region 125 of the fluid impermeable collection bag 120. The additional fluid permeable body 130 may be configured to wick or draw fluid away from the plurality of apertures 122 into the interior region 125 of the fluid impermeable collection bag 125. In some embodiments, the additional fluid permeable body 130 may include any of the materials described above in relation to the fluid permeable body 110. The additional fluid permeable body 130 may cover at least a portion (e.g., all) of the plurality of apertures 122. In some embodiments, the additional fluid permeable body 130 may be adjacent to the plurality of apertures 122 and/or interfacing the region of the back side 107 defining the plurality of apertures 122. For example, the additional fluid permeable body 130 may extend from the region of the back side 107 defining the plurality of apertures 122 into the interior region 125 of the fluid impermeable collection bag 120. In some embodiments, the additional fluid permeable body 120 fills at least a portion (e.g., all) of the interior region 125 of the fluid impermeable collection bag 120. In some embodiments, the additional fluid permeable body 120 extends from the plurality of apertures to the back of the fluid impermeable collection bag 120.
In use, in some conditions, the fluid permeable body 110 swells and capillaries within the fluid permeable body 110 are blocked, the wicking properties of the fluid collection device 100 are lowered or reduced. Thus, without a pump or vacuum source, the fluid collection device 100 may last longer because the urine can be transferred from the chamber 104 to the interior region 125 of the fluid impermeable collection bag 120. Transfer of the fluid from the chamber 104 through the plurality of apertures 122 and into the interior region 125 of the fluid impermeable collection bag 120 may happen mechanically (e.g., squeezing the fluid impermeable barrier 102) and/or through hydrophilic material properties, described in greater detail below. The interior region 125 of the fluid impermeable collection bag 120 may include at least one of an odor elimination agent (such as vitamin C) or a solidifying agent (such as gel beads). In some embodiments, the additional fluid permeable body 130 may be absent and the interior region 125 is open space void of other materials.
The additional fluid permeable body 200 also may include strips, sheets, columns, or cylinders of wicking material 206 and strips, sheets, columns, or cylinders of absorbent material 204 extending from the wicking material 202. The region of wicking material 202 and/or the strips of wicking material 206 may include one or more of bamboo fiber, cotton fiber, hemp fiber, microfiber, or combinations thereof. The strips of absorbent material 204 may include sodium polyacrylate, cross-linked co-polymers of acrylamide and potassium acrylate, reclaimed fluff pulp, or other absorbent material(s) can be used as well.
In some embodiments, the strips of wicking material 206 and the strips of absorbent material 204 may be oriented in a direction of the flow of fluid in the additional fluid permeable body 200 due to gravity. The strips of wicking material 206 and strips of absorbent material 204 may be arranged in an alternating configuration such that each strip of wicking material is positioned adjacent to one or two strips of absorbent material 204, and each strip of absorbent material 204 is positioned adjacent to one or two strips of wicking material 206. For example, the additional fluid permeable body 200 may include a first strip 204a of absorbent material extending from the region of wicking material 202, a first strip 206a of additional wicking material extending from the region of wicking material 202 and positioned adjacent to the first strip 204a of absorbent material, a second strip 204b of absorbent material extending from the region of wicking material 202 and positioned adjacent to the first strip 206a of additional wicking material such that the first strip 206a of additional wicking material is positioned between the first strip 204a of absorbent material and the second strip 204b of absorbent material, and a second strip 206b of additional wicking material extending from the region of wicking material 202 and positioned adjacent to the second strip 204b of absorbent material such that the second strip of absorbent material 204b is positioned between the first strip 206a of additional wicking material and the second strip 206b of additional wicking material. The strips 206n of additional wicking material and the strips 204n of absorbent material continue this alternating arrangement. In some embodiments, the additional fluid permeable body 210 may include a grid of rows and columns each including alternating strips of absorbent material and strips of wicking material. The orientation of the strips of wicking material 206 and the strips of absorbent material 204 speed up the urine transportation from the chamber 104 of the fluid impermeable barrier 102 into the interior region 125 of the fluid impermeable collection bag 120 to prevent flooding or overflow of the fluid collection device 100. In such a structured combination, the strips of absorbent material 204 will not form a continuous gel layer that would slow down the speed of transfer of urine into the interior region 125 of the fluid impermeable collection bag 120. Performance of the fluid collection device 100 may be improved as the additional fluid permeable body 200 continues to function until full saturation. The strips of wicking material 206 may interface or be spaced from adjacent strips of the strips of absorbent material 204.
The additional fluid permeable body 250 may include strips of additional wicking material 256, such as strips 256a, 256b, 256n. Unless otherwise noted, the strips of additional wicking material 256 include any aspect of the strips of additional wicking material 206, including material and/or positioning relative to the strips of absorbent material 204. In some embodiments, the strips of wicking material 256 may include a hydrophilic coating 258 on the strips of wicking material 256 that create a gradient in hydrophilicity that increases along direction of the flow of fluid due to gravity. This gradient in hydrophilicity may provide a continued, capillary draw for the fluid to flow.
Returning to
The support member 115 is configured to bend or manipulate, and retain the shape manipulated to after manipulation. This support member 115, then, provides a more controllable fluid collection device 100 that can be manipulated into at least a partially compact configuration. For example, the support member 115 may be configured to be manipulated to a generally planar shape and retain the generally planar shape, thereby supporting the back side 107 of the fluid impermeable barrier 205 along an imaginary or theoretical plane. The support member 115 also may be configured to be manipulated to a generally curved, contoured, or arced shape and retain the generally curved or arced shape, thereby supporting the back side 109 of the fluid impermeable barrier 102 in a generally curved, contoured, or arced shape (similar to that of the fluid collection device 100 shown in
The support member 115 may include a shape memory material, such as a shape memory polymer or a metal (e.g., shape memory metal). Suitable shape memory materials are composed to adopt an intermediate or permanent shape in response to a stimuli. The stimuli may include an external physical force (e.g., bending force), heat, electrical bias, or a magnetic field. While the term “shape memory” is used to describe some of the “shape memory materials” herein, it should be understood that, in some examples, the material modified by the term “shape memory” may not necessarily need to return to a preselected shape upon application of a stimuli, as understood as the classical definition of the “shape memory material.” Rather, at least some of the shape memory materials herein may simply hold a selected shape when bent, set, or cured into a specific shape and/or when cooled in a specific shape, regardless of the stimuli applied thereto after. The shape memory materials may be returned to the original shape or changed to a new shape by application of stimuli. For example, a metal wire bent to a first shape may be utilized as the shape memory material, whereinafter the metal wire may be modified to a second shape via physical force applied thereto or via heating.
In an embodiment, the shape memory material may include metal, such as an elemental metal, an alloy, or shape memory alloy. Suitable shape memory metals may include standard steels, stainless steel, carbon alloy steel, head treated steel, aluminum, silver, copper, iron, nickel, zinc, tin, beryllium, or the like. Suitable shape memory alloys may include stainless steel; galvanized steel; aluminum alloys; nickel-titanium alloys, such as Nitinol, Ni—Ti—Cu, Ni—Ti, Co, or the like; copper-based alloys such as Cu—Zn—Al, Cu—Al—Ni, Cu—Al—Sn, or the like; Co—Cr—Ni—Mo alloys (e.g., Elgiloy®) or the like; or any other alloy having shape memory characteristics. As explained above, the shape memory metals or alloys may merely be metals or alloys that may be shaped to a selected configuration. In some examples, the shape memory metals or alloys may return to a primary shape when an external stimuli is applied thereto. In some examples, the outer surface of the shape memory metal may be coated with a polymer, anodized, passivated, or otherwise treated to prevent corrosion.
Shape memory polymers (“SMPs”) may include polyurethane-based SMPs such as a copolymer (e.g., copolyester, polyurethane, polyetherester, etc.) including blocks of one or more of poly(ε-caprolactone), polyethyleneterephthalate (PET), polyethyleneoxide (PEO), polyethylene glycol (PEG), polystyrene, polymethylmethacrylate (PMMA), Polybutylmethacrylate (PBMA), poly(N,N-butadiene), poly(N-methyl-N-oxazoline), polytetrahydrofuran, or poly(butylene terephthalate); thermoplastic polymers such as polyether ether ketone (PEEK), nylon, acetal, polytetrafluoroethylene (PTFE), polysulphone, or the like; Polynorbonene; other deformable polymers; or any other shape memory polymer.
Turning now to
The fluid collection device 300 also may include an aperture 312 or port positioned on the back side 307 of the fluid impermeable barrier 302 between the proximal end region 303 and the distal end region 305. The aperture 312 may be sized to allow a conduit 308 (e.g., tube) to slide or otherwise extend therethrough. The conduit 308 extends through the aperture 312, a seal is formed around the conduit 308 that prevents fluid from leaking through the aperture 312. The aperture 312 may be positioned approximately halfway between the proximal end region 303 and the distal end region 305.
The conduit 308 may extend through the aperture 312 into the chamber and at least proximate to the distal end region 305. The conduit 308 may include at least one opening or inlet at a terminating end of the conduit 308 positioned within the chamber. In some embodiments, the conduit 308 includes multiple openings 311 positioned in the chamber between the terminating end and the aperture 312. The openings 311 in the conduit 308 provide fluid communication between the chamber and the conduit 308. The conduit 308 may be configured to provide fluid communication between a vacuum source and the chamber of the fluid collection device 312 to draw fluid from the chamber and through the conduit 308 for collection.
The suction force may be applied to the outlet of the tube 17 by the vacuum source 16 either directly or indirectly. The suction force may be applied indirectly via the fluid collection container 14. For example, the outlet of the tube 17 may be disposed within or fluidly coupled to an interior region of the fluid collection container 14 and an additional tube 17 may extend from the fluid collection container 14 to the vacuum source 16. Accordingly, the vacuum 16 may apply suction to the fluid collection device 12 via the fluid collection container 14. The suction force may be applied directly via the vacuum source 16. For example, the outlet of the tube 17 may be disposed within the vacuum source 16. An additional tube 17 may extend from the vacuum source 16 to a point outside of the fluid collection device 12, such as to the fluid collection container 14. In such examples, the vacuum source 16 may be disposed between the fluid collection device 12 and the fluid collection container 14.
The fluid collection container 14 is sized and shaped to retain a fluid therein. The fluid collection container 14 may include a bag (e.g., drainage bag), a bottle or cup (e.g., collection jar), or any other enclosed container for storing bodily fluid(s) such as urine. In some examples, the tube 17 may extend from the fluid collection device 12 and attach to the fluid collection container 14 at a first point therein. An additional tube 17 may attach to the fluid collection container 14 at a second point thereon and may extend and attach to the vacuum source 16. Accordingly, a vacuum (e.g., suction) may be drawn through fluid collection device 12 via the fluid collection container 14. Fluid, such as urine, may be drained from the fluid collection device 12 using the vacuum source 16.
The vacuum source 16 may include one or more of a manual vacuum pump, and electric vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any source configured to produce a vacuum (e.g., negative pressure). The vacuum source 16 may provide a vacuum or suction to remove fluid from the fluid collection device 12. In some examples, the vacuum source 16 may be powered by one or more of a power cord (e.g., connected to a power socket), one or more batteries, or even manual power (e.g., a hand operated vacuum pump). In some examples, the vacuum source 16 may be sized and shaped to fit outside of, on, or within the fluid collection device 12. For example, the vacuum source 16 may include one or more miniaturized pumps or one or more micro pumps. The vacuum sources disclosed herein may include one or more of a switch, a button, a plug, a remote, or any other device suitable to activate the vacuum source 16. Aspects of the fluid collection system 10 may be included in any of the fluid collection systems described herein. For example, the fluid collection device 12 may include any of the fluid or urine collection devices described herein.
Turning to
Turning to
In some embodiments, the act 530 of passing the fluid in the chamber through one or more apertures on a back side of the fluid impermeable barrier may include passing the fluid in the chamber through a plurality of apertures on the back side of the fluid impermeable barrier into an interior region of a fluid impermeable collection bag secured to the fluid impermeable barrier. More particularly, passing the fluid in the chamber through a plurality of apertures on the back side of the fluid impermeable barrier into a fluid impermeable collection bag secured to the fluid impermeable barrier may include squeezing the fluid impermeable barrier effective to force the fluid in the chamber through the plurality of apertures into the interior region of the fluid impermeable collection bag.
In some embodiments, the method 500 may include an act of drawing the fluid in the interior region of the fluid impermeable collection bag away from the plurality of openings with an additional fluid permeable body including at least a region of wicking material positioned adjacent to the plurality of apertures in the fluid impermeable barrier. More particularly, the method may include drawing the fluid in the interior region of the fluid impermeable collection bag away from the plurality of openings with an additional fluid impermeable barrier including the region of wicking material positioned adjacent to the one or more apertures, a first of strip of absorbent material extending from the region of wicking material, a first strip of additional wicking material extending from the region of wicking material and positioned adjacent to the first strip of absorbent material, a second strip of absorbent material extending from the region of wicking material and positioned adjacent to the first strip of additional wicking material such that the first strip of additional wicking material is positioned between the first strip of absorbent material and the second strip of absorbent material, and a second strip of additional wicking material extending from the region of wicking material and positioned adjacent to the second strip of absorbent material such that the second strip of absorbent material is positioned between the first strip of additional wicking material and the second strip of additional wicking material. Each of the first strip of additional wicking material and the second strip of additional wicking material may include a hydrophilic coating on a distal region that is distal to the region of wicking material.
In some embodiments, the act 530 of passing the fluid in the chamber through one or more apertures on a back side of the fluid impermeable barrier may include passing the fluid through a conduit extending through one aperture, the conduit extending at least partially into the chamber.
The method 500 may further include an act of bending the fluid collection device in a curve or contour complementary to user. The fluid collection device may include a support member secured to the fluid collection device and configured to retain the fluid collection device in the curve complementary to the user. The method 500 may further include an act of holding the fluid collection device against the user with a flap of an undergarment held in a closed position with one or more securement elements. The method 500 may further comprise an act of securing the undergarment to the user with one or more side securement elements securing a front side of the undergarment to a back side of the undergarment.
The acts of the method 500 described above are for illustrative purposes. For example, the acts of the method 500 can be performed in different orders, split into multiple acts, modified, supplemented, or combined. In an embodiment, one or more of the acts of the method 500 can be omitted from the method 500. Any of the acts of the method 500 can include using any of the fluid collection systems disclosed herein.
As used herein, the term “about” or “substantially” refers to an allowable variance of the term modified by “about” or “substantially” by ±10% or ±5%. Further, the terms “less than,” “or less,” “greater than,” “more than,” or “or more” include, as an endpoint, the value that is modified by the terms “less than,” “or less,” “greater than,” “more than,” or “or more.”
While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiments disclosed herein are for purposes of illustration and are not intended to be limiting.
This application claims priority to U.S. Provisional Patent Application No. 63/171,165 filed on Apr. 6, 2021, the disclosure of which is incorporated herein, in its entirety, by this reference.
Number | Name | Date | Kind |
---|---|---|---|
737443 | Mooers | Aug 1903 | A |
1032841 | Koenig | Jul 1912 | A |
1178644 | Johnson | Apr 1916 | A |
1742080 | Jones | Dec 1929 | A |
1979899 | Obrien et al. | Nov 1934 | A |
2241010 | Chipley | May 1941 | A |
2262772 | Peder | Nov 1941 | A |
2326881 | Packer | Aug 1943 | A |
2379346 | Farrell | Jun 1945 | A |
2485555 | Bester | Oct 1949 | A |
2613670 | Edward | Oct 1952 | A |
2616426 | Adele | Nov 1952 | A |
2644234 | Earl | Jul 1953 | A |
2648335 | Chambers | Aug 1953 | A |
2859786 | Tupper | Nov 1958 | A |
2944551 | Carl | Jul 1960 | A |
2968046 | Duke | Jan 1961 | A |
2971512 | Reinhardt | Feb 1961 | A |
3032038 | Swinn | May 1962 | A |
3077883 | Hill | Feb 1963 | A |
3087938 | Hans et al. | Apr 1963 | A |
3169528 | Knox et al. | Feb 1965 | A |
3171506 | Therkel | Mar 1965 | A |
3194238 | Breece | Jul 1965 | A |
3198994 | Hildebrandt et al. | Aug 1965 | A |
3221742 | Egon | Dec 1965 | A |
3312221 | Overment | Apr 1967 | A |
3312981 | McGuire et al. | Apr 1967 | A |
3349768 | Keane | Oct 1967 | A |
3362590 | Gene | Jan 1968 | A |
3366116 | Huck | Jan 1968 | A |
3398848 | Donovan | Aug 1968 | A |
3400717 | Bruce et al. | Sep 1968 | A |
3406688 | Bruce | Oct 1968 | A |
3424163 | Gravdahl | Jan 1969 | A |
3425471 | Yates | Feb 1969 | A |
3511241 | Lee | May 1970 | A |
3512185 | Ellis | May 1970 | A |
3520300 | Flower | Jul 1970 | A |
3528423 | Lee | Sep 1970 | A |
3613123 | Langstrom | Oct 1971 | A |
3648700 | Warner | Mar 1972 | A |
3651810 | Ormerod | Mar 1972 | A |
3661155 | Lindan | May 1972 | A |
3683918 | Pizzella | Aug 1972 | A |
3699815 | Holbrook | Oct 1972 | A |
3726277 | Hirschman | Apr 1973 | A |
3742952 | Magers et al. | Jul 1973 | A |
3757355 | Allen et al. | Sep 1973 | A |
3788324 | Lim | Jan 1974 | A |
3843016 | Bornhorst et al. | Oct 1974 | A |
3863638 | Rogers et al. | Feb 1975 | A |
3863798 | Kurihara et al. | Feb 1975 | A |
3864759 | Horiuchi | Feb 1975 | A |
3881486 | Fenton | May 1975 | A |
3881489 | Hartwell | May 1975 | A |
3915189 | Holbrook et al. | Oct 1975 | A |
3998228 | Poidomani | Dec 1976 | A |
3999550 | Martin | Dec 1976 | A |
4015604 | Csillag | Apr 1977 | A |
4020843 | Kanall | May 1977 | A |
4022213 | Stein | May 1977 | A |
4027776 | Douglas | Jun 1977 | A |
4064962 | Hunt | Dec 1977 | A |
4116197 | Bermingham | Sep 1978 | A |
4180178 | Turner | Dec 1979 | A |
4187953 | Turner | Feb 1980 | A |
4194508 | Anderson | Mar 1980 | A |
4200102 | Duhamel et al. | Apr 1980 | A |
4202058 | Anderson | May 1980 | A |
4203503 | Bertotti et al. | May 1980 | A |
4209076 | Bertotti et al. | Jun 1980 | A |
4233025 | Larson et al. | Nov 1980 | A |
4233978 | Hickey | Nov 1980 | A |
4246901 | Frosch et al. | Jan 1981 | A |
4253542 | Ruspa et al. | Mar 1981 | A |
4257418 | Hessner | Mar 1981 | A |
4270539 | Frosch et al. | Jun 1981 | A |
4281655 | Terauchi | Aug 1981 | A |
4292916 | Bradley et al. | Oct 1981 | A |
4330239 | Gannaway | May 1982 | A |
4352356 | Tong | Oct 1982 | A |
4360933 | Kimura et al. | Nov 1982 | A |
4365363 | Windauer | Dec 1982 | A |
4375841 | Vielbig | Mar 1983 | A |
4387726 | Denard | Jun 1983 | A |
4425130 | Desmarais | Jan 1984 | A |
4446986 | Bowen et al. | May 1984 | A |
4453938 | Brendling | Jun 1984 | A |
4457314 | Knowles | Jul 1984 | A |
4476879 | Jackson | Oct 1984 | A |
4526688 | Schmidt et al. | Jul 1985 | A |
4528703 | Kraus | Jul 1985 | A |
D280438 | Wendt | Sep 1985 | S |
4551141 | McNeil | Nov 1985 | A |
4553968 | Komis | Nov 1985 | A |
4581026 | Schneider | Apr 1986 | A |
4589516 | Inoue et al. | May 1986 | A |
4601716 | Smith | Jul 1986 | A |
4610675 | Triunfol | Sep 1986 | A |
4620333 | Ritter | Nov 1986 | A |
4626250 | Schneider | Dec 1986 | A |
4627846 | Ternstroem | Dec 1986 | A |
4631061 | Martin | Dec 1986 | A |
4650477 | Johnson | Mar 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4656675 | Fajnsztajn | Apr 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4681577 | Stern et al. | Jul 1987 | A |
4692160 | Nussbaumer | Sep 1987 | A |
4707864 | Ikematsu et al. | Nov 1987 | A |
4713065 | Koot | Dec 1987 | A |
4713066 | Komis | Dec 1987 | A |
4735841 | Sourdet | Apr 1988 | A |
4743236 | Manschot | May 1988 | A |
4747166 | Kuntz | May 1988 | A |
4752944 | Conrads et al. | Jun 1988 | A |
4769215 | Ehrenkranz | Sep 1988 | A |
4771484 | Mozell | Sep 1988 | A |
4772280 | Rooyakkers | Sep 1988 | A |
4790830 | Hamacher | Dec 1988 | A |
4790835 | Elias | Dec 1988 | A |
4791686 | Taniguchi et al. | Dec 1988 | A |
4795449 | Schneider et al. | Jan 1989 | A |
4798603 | Meyer et al. | Jan 1989 | A |
4799928 | Crowley | Jan 1989 | A |
4804377 | Hanifl et al. | Feb 1989 | A |
4812053 | Bhattacharjee | Mar 1989 | A |
4813943 | Smith | Mar 1989 | A |
4820297 | Kaufman et al. | Apr 1989 | A |
4846818 | Keldahl et al. | Jul 1989 | A |
4846909 | Klug et al. | Jul 1989 | A |
4865595 | Heyden | Sep 1989 | A |
4880417 | Yabrov et al. | Nov 1989 | A |
4882794 | Stewart | Nov 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4886498 | Newton | Dec 1989 | A |
4886508 | Washington | Dec 1989 | A |
4886509 | Mattsson | Dec 1989 | A |
4889532 | Metz et al. | Dec 1989 | A |
4889533 | Beecher | Dec 1989 | A |
4890691 | Ching-Ho | Jan 1990 | A |
4903254 | Haas | Feb 1990 | A |
4904248 | Vaillancourt | Feb 1990 | A |
4905692 | More | Mar 1990 | A |
4936838 | Cross et al. | Jun 1990 | A |
4955922 | Terauchi | Sep 1990 | A |
4957487 | Gerow | Sep 1990 | A |
4965460 | Tanaka et al. | Oct 1990 | A |
4987849 | Sherman | Jan 1991 | A |
5002541 | Conkling et al. | Mar 1991 | A |
5004463 | Nigay | Apr 1991 | A |
5031248 | Kemper | Jul 1991 | A |
5045077 | Blake | Sep 1991 | A |
5045283 | Patel | Sep 1991 | A |
5049144 | Payton | Sep 1991 | A |
5053339 | Patel | Oct 1991 | A |
5057092 | Webster | Oct 1991 | A |
5058088 | Haas et al. | Oct 1991 | A |
5071347 | McGuire | Dec 1991 | A |
5078707 | Peter | Jan 1992 | A |
5084037 | Barnett | Jan 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5112324 | Wallace | May 1992 | A |
5147301 | Ruvio | Sep 1992 | A |
5176667 | Debring | Jan 1993 | A |
5195997 | Carns | Mar 1993 | A |
5196654 | Diflora et al. | Mar 1993 | A |
5203699 | McGuire | Apr 1993 | A |
5244458 | Takasu | Sep 1993 | A |
5246454 | Peterson | Sep 1993 | A |
5267988 | Farkas | Dec 1993 | A |
5275307 | Freese | Jan 1994 | A |
5294983 | Ersoz et al. | Mar 1994 | A |
5295983 | Kubo | Mar 1994 | A |
5300052 | Kubo | Apr 1994 | A |
5304749 | Crandell | Apr 1994 | A |
5312383 | Kubalak | May 1994 | A |
5318550 | Cermak et al. | Jun 1994 | A |
5330459 | Lavon et al. | Jul 1994 | A |
5340840 | Park et al. | Aug 1994 | A |
5382244 | Telang | Jan 1995 | A |
5409014 | Napoli et al. | Apr 1995 | A |
5411495 | Willingham | May 1995 | A |
5423784 | Metz | Jun 1995 | A |
5456246 | Schmieding et al. | Oct 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5478334 | Bernstein | Dec 1995 | A |
5499977 | Marx | Mar 1996 | A |
5543042 | Filan et al. | Aug 1996 | A |
D373928 | Green | Sep 1996 | S |
5582604 | Ahr et al. | Dec 1996 | A |
5592950 | Kopelowicz | Jan 1997 | A |
5605161 | Cross | Feb 1997 | A |
5618277 | Goulter | Apr 1997 | A |
5628735 | Skow | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5637104 | Ball et al. | Jun 1997 | A |
5674212 | Osborn et al. | Oct 1997 | A |
5678564 | Lawrence | Oct 1997 | A |
5678654 | Uzawa | Oct 1997 | A |
5687429 | Rahlff | Nov 1997 | A |
5695485 | Duperret et al. | Dec 1997 | A |
5700254 | McDowall et al. | Dec 1997 | A |
5705777 | Flanigan et al. | Jan 1998 | A |
5752944 | Dann et al. | May 1998 | A |
5772644 | Bark et al. | Jun 1998 | A |
5792132 | Garcia | Aug 1998 | A |
5827243 | Palestrant | Oct 1998 | A |
5827247 | Kay | Oct 1998 | A |
5827250 | Fujioka et al. | Oct 1998 | A |
5827257 | Fujioka et al. | Oct 1998 | A |
D401699 | Herchenbach et al. | Nov 1998 | S |
5859393 | Cummins et al. | Jan 1999 | A |
5865378 | Hollinshead et al. | Feb 1999 | A |
5876393 | Ahr et al. | Mar 1999 | A |
5887291 | Bellizzi | Mar 1999 | A |
5894608 | Birbara | Apr 1999 | A |
D409303 | Oepping | May 1999 | S |
5911222 | Lawrence et al. | Jun 1999 | A |
5957904 | Holland | Sep 1999 | A |
5968026 | Osborn et al. | Oct 1999 | A |
5972505 | Phillips et al. | Oct 1999 | A |
6039060 | Rower | Mar 2000 | A |
6050983 | Moore et al. | Apr 2000 | A |
6059762 | Boyer et al. | May 2000 | A |
6063064 | Tuckey et al. | May 2000 | A |
6098625 | Winkler | Aug 2000 | A |
6105174 | Karlsten et al. | Aug 2000 | A |
6113582 | Dwork | Sep 2000 | A |
6117163 | Bierman | Sep 2000 | A |
6123398 | Arai et al. | Sep 2000 | A |
6129718 | Wada et al. | Oct 2000 | A |
6131964 | Sareshwala | Oct 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6164569 | Hollinshead et al. | Dec 2000 | A |
6177606 | Etheredge et al. | Jan 2001 | B1 |
6209142 | Mattsson et al. | Apr 2001 | B1 |
6220050 | Cooksey | Apr 2001 | B1 |
6244311 | Hand et al. | Jun 2001 | B1 |
6248096 | Dwork et al. | Jun 2001 | B1 |
6263887 | Dunn | Jul 2001 | B1 |
6283246 | Nishikawa | Sep 2001 | B1 |
6311339 | Kraus | Nov 2001 | B1 |
6336919 | Davis et al. | Jan 2002 | B1 |
6338729 | Wada et al. | Jan 2002 | B1 |
6352525 | Wakabayashi | Mar 2002 | B1 |
6394988 | Hashimoto | May 2002 | B1 |
6398742 | Kim | Jun 2002 | B1 |
6406463 | Brown | Jun 2002 | B1 |
6409712 | Dutari et al. | Jun 2002 | B1 |
6416500 | Wada et al. | Jul 2002 | B1 |
6423045 | Wise et al. | Jul 2002 | B1 |
6428521 | Droll | Aug 2002 | B1 |
6428522 | Dipalma et al. | Aug 2002 | B1 |
6446454 | Lee et al. | Sep 2002 | B1 |
6475198 | Lipman et al. | Nov 2002 | B1 |
6479726 | Cole et al. | Nov 2002 | B1 |
6491673 | Palumbo et al. | Dec 2002 | B1 |
6508794 | Palumbo et al. | Jan 2003 | B1 |
6524292 | Dipalma et al. | Feb 2003 | B1 |
6540729 | Wada et al. | Apr 2003 | B1 |
6547771 | Robertson et al. | Apr 2003 | B2 |
6569133 | Cheng et al. | May 2003 | B2 |
D476518 | Doppelt | Jul 2003 | S |
6592560 | Snyder et al. | Jul 2003 | B2 |
6610038 | Dipalma et al. | Aug 2003 | B1 |
6618868 | Minnick | Sep 2003 | B2 |
6620142 | Flueckiger | Sep 2003 | B1 |
6629651 | Male et al. | Oct 2003 | B1 |
6635038 | Scovel | Oct 2003 | B2 |
6652495 | Walker | Nov 2003 | B1 |
6666850 | Ahr et al. | Dec 2003 | B1 |
6685684 | Falconer | Feb 2004 | B1 |
6695828 | Dipalma et al. | Feb 2004 | B1 |
6700034 | Lindsay et al. | Mar 2004 | B1 |
6702793 | Sweetser | Mar 2004 | B1 |
6706027 | Harvie et al. | Mar 2004 | B2 |
6732384 | Scott | May 2004 | B2 |
6736977 | Hall et al. | May 2004 | B1 |
6740066 | Wolff et al. | May 2004 | B2 |
6764477 | Chen et al. | Jul 2004 | B1 |
6783519 | Samuelsson | Aug 2004 | B2 |
6796974 | Palumbo et al. | Sep 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6849065 | Schmidt et al. | Feb 2005 | B2 |
6857137 | Otto | Feb 2005 | B2 |
6885690 | Aggerstam et al. | Apr 2005 | B2 |
6888044 | Fell et al. | May 2005 | B2 |
6893425 | Dunn et al. | May 2005 | B2 |
6912737 | Ernest | Jul 2005 | B2 |
6918899 | Harvie | Jul 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7018366 | Easter | Mar 2006 | B2 |
7066411 | Male et al. | Jun 2006 | B2 |
7122023 | Hinoki | Oct 2006 | B1 |
7125399 | Miskie | Oct 2006 | B2 |
7131964 | Harvie | Nov 2006 | B2 |
7135012 | Harvie | Nov 2006 | B2 |
7141043 | Harvie | Nov 2006 | B2 |
D533972 | La | Dec 2006 | S |
7160273 | Greter et al. | Jan 2007 | B2 |
7171699 | Ernest et al. | Feb 2007 | B2 |
7171871 | Kozak | Feb 2007 | B2 |
7179951 | Krishnaswamy-Mirle et al. | Feb 2007 | B2 |
7181781 | Trabold et al. | Feb 2007 | B1 |
7186245 | Cheng et al. | Mar 2007 | B1 |
7192424 | Cooper | Mar 2007 | B2 |
7219764 | Forbes | May 2007 | B1 |
7220250 | Suzuki et al. | May 2007 | B2 |
D562975 | Otto | Feb 2008 | S |
7335189 | Harvie | Feb 2008 | B2 |
7358282 | Krueger et al. | Apr 2008 | B2 |
7390320 | Machida et al. | Jun 2008 | B2 |
7438706 | Koizumi et al. | Oct 2008 | B2 |
7488310 | Yang | Feb 2009 | B2 |
7491194 | Oliwa | Feb 2009 | B1 |
D591106 | Dominique et al. | Apr 2009 | S |
7513381 | Heng et al. | Apr 2009 | B2 |
7520872 | Biggie et al. | Apr 2009 | B2 |
D593801 | Wilson et al. | Jun 2009 | S |
7540364 | Sanderson | Jun 2009 | B2 |
7549512 | Newberry | Jun 2009 | B2 |
7585293 | Vermaak | Sep 2009 | B2 |
7588560 | Dunlop | Sep 2009 | B1 |
7665359 | Barber | Feb 2010 | B2 |
7682347 | Parks et al. | Mar 2010 | B2 |
7687004 | Allen | Mar 2010 | B2 |
7695459 | Gilbert et al. | Apr 2010 | B2 |
7695460 | Wada et al. | Apr 2010 | B2 |
7699818 | Gilbert | Apr 2010 | B2 |
7699831 | Bengtson et al. | Apr 2010 | B2 |
7722584 | Tanaka et al. | May 2010 | B2 |
7727206 | Gorres | Jun 2010 | B2 |
7740620 | Gilbert et al. | Jun 2010 | B2 |
7749205 | Tazoe et al. | Jul 2010 | B2 |
7755497 | Wada et al. | Jul 2010 | B2 |
7766887 | Burns et al. | Aug 2010 | B2 |
D625407 | Koizumi et al. | Oct 2010 | S |
7806879 | Brooks et al. | Oct 2010 | B2 |
7811272 | Lindsay et al. | Oct 2010 | B2 |
7815067 | Matsumoto et al. | Oct 2010 | B2 |
7833169 | Hannon | Nov 2010 | B2 |
7857806 | Karpowicz et al. | Dec 2010 | B2 |
7866942 | Harvie | Jan 2011 | B2 |
7871385 | Levinson et al. | Jan 2011 | B2 |
7875010 | Frazier et al. | Jan 2011 | B2 |
7901389 | Mombrinie | Mar 2011 | B2 |
7927320 | Goldwasser et al. | Apr 2011 | B2 |
7927321 | Marland | Apr 2011 | B2 |
7931634 | Swiecicki et al. | Apr 2011 | B2 |
7939706 | Okabe et al. | May 2011 | B2 |
7946443 | Stull et al. | May 2011 | B2 |
7947025 | Buglino et al. | May 2011 | B2 |
7963419 | Burney et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7993318 | Olsson et al. | Aug 2011 | B2 |
8015627 | Baker et al. | Sep 2011 | B2 |
8016071 | Martinus et al. | Sep 2011 | B1 |
8028460 | Williams | Oct 2011 | B2 |
8047398 | Dimartino et al. | Nov 2011 | B2 |
8083094 | Caulfield et al. | Dec 2011 | B2 |
8128608 | Thevenin | Mar 2012 | B2 |
8181651 | Pinel | May 2012 | B2 |
8181819 | Burney et al. | May 2012 | B2 |
8211063 | Bierman et al. | Jul 2012 | B2 |
8221369 | Parks et al. | Jul 2012 | B2 |
8241262 | Mahnensmith | Aug 2012 | B2 |
8277426 | Wilcox et al. | Oct 2012 | B2 |
8287508 | Sanchez | Oct 2012 | B1 |
8303554 | Tsai et al. | Nov 2012 | B2 |
8322565 | Caulfield et al. | Dec 2012 | B2 |
8337477 | Parks et al. | Dec 2012 | B2 |
D674241 | Bickert et al. | Jan 2013 | S |
8343122 | Gorres | Jan 2013 | B2 |
8343125 | Kawazoe et al. | Jan 2013 | B2 |
8353074 | Krebs | Jan 2013 | B2 |
8353886 | Bester et al. | Jan 2013 | B2 |
D676241 | Merrill | Feb 2013 | S |
8388588 | Wada et al. | Mar 2013 | B2 |
D679807 | Burgess et al. | Apr 2013 | S |
8425482 | Khoubnazar | Apr 2013 | B2 |
8434586 | Pawelski et al. | May 2013 | B2 |
8449510 | Martini et al. | May 2013 | B2 |
D684260 | Lund et al. | Jun 2013 | S |
8470230 | Caulfield et al. | Jun 2013 | B2 |
8479941 | Matsumoto et al. | Jul 2013 | B2 |
8479949 | Henkel | Jul 2013 | B2 |
8500719 | Simpson et al. | Aug 2013 | B1 |
8512301 | Ma | Aug 2013 | B2 |
8529530 | Koch et al. | Sep 2013 | B2 |
8535284 | Joder et al. | Sep 2013 | B2 |
8546639 | Wada et al. | Oct 2013 | B2 |
8551075 | Bengtson | Oct 2013 | B2 |
8568376 | Delattre et al. | Oct 2013 | B2 |
D694404 | Burgess et al. | Nov 2013 | S |
8585683 | Bengtson et al. | Nov 2013 | B2 |
8586583 | Hamblin et al. | Nov 2013 | B2 |
8652112 | Johannison et al. | Feb 2014 | B2 |
8669412 | Fernkvist et al. | Mar 2014 | B2 |
D702973 | Norland et al. | Apr 2014 | S |
8703032 | Menon et al. | Apr 2014 | B2 |
D704330 | Cicatelli | May 2014 | S |
D704510 | Mason et al. | May 2014 | S |
D705423 | Walsh Cutler | May 2014 | S |
D705926 | Burgess et al. | May 2014 | S |
8714394 | Wulf | May 2014 | B2 |
8715267 | Bengtson et al. | May 2014 | B2 |
8757425 | Copeland | Jun 2014 | B2 |
8777032 | Biesecker et al. | Jul 2014 | B2 |
8808260 | Koch et al. | Aug 2014 | B2 |
8864730 | Conway et al. | Oct 2014 | B2 |
8881923 | Higginson | Nov 2014 | B2 |
8882731 | Suzuki et al. | Nov 2014 | B2 |
8936585 | Carson et al. | Jan 2015 | B2 |
D729581 | Boroski | May 2015 | S |
9028460 | Medeiros | May 2015 | B2 |
9056698 | Noer | Jun 2015 | B2 |
9078792 | Ruiz | Jul 2015 | B2 |
9145879 | Pirovano et al. | Sep 2015 | B2 |
9173602 | Gilbert | Nov 2015 | B2 |
9173799 | Tanimoto et al. | Nov 2015 | B2 |
9187220 | Biesecker et al. | Nov 2015 | B2 |
9199772 | Krippendorf | Dec 2015 | B2 |
9233020 | Matsumiya | Jan 2016 | B2 |
9248058 | Conway et al. | Feb 2016 | B2 |
9308118 | Dupree et al. | Apr 2016 | B1 |
9309029 | Incorvia et al. | Apr 2016 | B2 |
9333281 | Giezendanner et al. | May 2016 | B2 |
9381108 | Longoni et al. | Jul 2016 | B2 |
9382047 | Schmidtner et al. | Jul 2016 | B2 |
9402424 | Roy | Aug 2016 | B2 |
9456937 | Ellis | Oct 2016 | B2 |
9480595 | Baham et al. | Nov 2016 | B2 |
9517865 | Albers et al. | Dec 2016 | B2 |
D777941 | Piramoon | Jan 2017 | S |
9533806 | Ding et al. | Jan 2017 | B2 |
9550611 | Hodge | Jan 2017 | B2 |
9555930 | Campbell et al. | Jan 2017 | B2 |
9623159 | Locke | Apr 2017 | B2 |
D789522 | Burgess et al. | Jun 2017 | S |
9687849 | Bruno et al. | Jun 2017 | B2 |
9694949 | Hendricks et al. | Jul 2017 | B2 |
9709048 | Kinjo | Jul 2017 | B2 |
9713547 | Lee et al. | Jul 2017 | B2 |
9732754 | Huang et al. | Aug 2017 | B2 |
9752564 | Arceno et al. | Sep 2017 | B2 |
9788992 | Harvie | Oct 2017 | B2 |
D804907 | Sandoval | Dec 2017 | S |
9868564 | McGirr et al. | Jan 2018 | B2 |
D814239 | Arora | Apr 2018 | S |
D817484 | Lafond | May 2018 | S |
10037640 | Gordon | Jul 2018 | B2 |
10058470 | Phillips | Aug 2018 | B2 |
10098990 | Koch et al. | Oct 2018 | B2 |
D835264 | Mozzicato et al. | Dec 2018 | S |
D835779 | Mozzicato et al. | Dec 2018 | S |
D840533 | Mozzicato et al. | Feb 2019 | S |
D840534 | Mozzicato et al. | Feb 2019 | S |
10225376 | Perez Martinez | Mar 2019 | B2 |
10226376 | Sanchez et al. | Mar 2019 | B2 |
10258517 | Maschino et al. | Apr 2019 | B1 |
D848612 | Mozzicato et al. | May 2019 | S |
10307305 | Hodges | Jun 2019 | B1 |
10335121 | Desai | Jul 2019 | B2 |
D856512 | Cowart et al. | Aug 2019 | S |
10376406 | Newton | Aug 2019 | B2 |
10376407 | Newton | Aug 2019 | B2 |
10390989 | Sanchez et al. | Aug 2019 | B2 |
D858144 | Fu | Sep 2019 | S |
10406039 | Mllarreal | Sep 2019 | B2 |
10407222 | Allen | Sep 2019 | B2 |
10478356 | Griffin | Nov 2019 | B2 |
10500108 | Maschino et al. | Dec 2019 | B1 |
10538366 | Pentelovitch et al. | Jan 2020 | B2 |
10569938 | Zhao et al. | Feb 2020 | B2 |
10577156 | Dagnelie et al. | Mar 2020 | B2 |
RE47930 | Cho | Apr 2020 | E |
10618721 | Vazin | Apr 2020 | B2 |
D884390 | Wang | May 2020 | S |
10669079 | Freedman et al. | Jun 2020 | B2 |
D892315 | Airy | Aug 2020 | S |
10730672 | Bertram et al. | Aug 2020 | B2 |
10737848 | Philip et al. | Aug 2020 | B2 |
10765854 | Law et al. | Sep 2020 | B2 |
10766670 | Kittmann | Sep 2020 | B2 |
10799386 | Harrison | Oct 2020 | B1 |
10806642 | Tagomori et al. | Oct 2020 | B2 |
D901214 | Hu | Nov 2020 | S |
10849799 | Nishikawa et al. | Dec 2020 | B2 |
10857025 | Davis et al. | Dec 2020 | B2 |
10865017 | Cowart et al. | Dec 2020 | B1 |
10889412 | West et al. | Jan 2021 | B2 |
10913581 | Stahlecker | Feb 2021 | B2 |
D912244 | Rehm et al. | Mar 2021 | S |
10952889 | Newton et al. | Mar 2021 | B2 |
10973378 | Ryu et al. | Apr 2021 | B2 |
10973678 | Newton et al. | Apr 2021 | B2 |
10974874 | Ragias et al. | Apr 2021 | B2 |
11000401 | Ecklund et al. | May 2021 | B2 |
D923365 | Wang | Jun 2021 | S |
11026829 | Harvie | Jun 2021 | B2 |
11027900 | Liu | Jun 2021 | B2 |
11045346 | Argent et al. | Jun 2021 | B2 |
D928946 | Sanchez et al. | Aug 2021 | S |
11160695 | Febo et al. | Nov 2021 | B2 |
11160697 | Maschino et al. | Nov 2021 | B2 |
11168420 | Kinugasa et al. | Nov 2021 | B2 |
11179506 | Barr et al. | Nov 2021 | B2 |
11226376 | Yamauchi et al. | Jan 2022 | B2 |
11253407 | Miao et al. | Feb 2022 | B2 |
11326586 | Milner et al. | May 2022 | B2 |
11369508 | Ecklund et al. | Jun 2022 | B2 |
11369524 | Hubbard et al. | Jun 2022 | B2 |
11376152 | Sanchez et al. | Jul 2022 | B2 |
11382786 | Sanchez et al. | Jul 2022 | B2 |
11382788 | Hjorth et al. | Jul 2022 | B2 |
11389318 | Radl et al. | Jul 2022 | B2 |
11395871 | Radl et al. | Jul 2022 | B2 |
11399990 | Suyama | Aug 2022 | B2 |
11426303 | Davis et al. | Aug 2022 | B2 |
11504265 | Godinez et al. | Nov 2022 | B2 |
11529252 | Glithero et al. | Dec 2022 | B2 |
11547788 | Radl et al. | Jan 2023 | B2 |
11806266 | Sanchez et al. | Nov 2023 | B2 |
D1010109 | Ecklund et al. | Jan 2024 | S |
11857716 | Lee et al. | Jan 2024 | B2 |
11890221 | Ulreich et al. | Feb 2024 | B2 |
11925575 | Newton | Mar 2024 | B2 |
11944740 | Hughett et al. | Apr 2024 | B2 |
20010037097 | Cheng et al. | Nov 2001 | A1 |
20010054426 | Knudson et al. | Dec 2001 | A1 |
20020019614 | Woon | Feb 2002 | A1 |
20020026161 | Grundke | Feb 2002 | A1 |
20020087131 | Wolff et al. | Jul 2002 | A1 |
20020091364 | Prabhakar | Jul 2002 | A1 |
20020189992 | Schmidt et al. | Dec 2002 | A1 |
20020193760 | Thompson | Dec 2002 | A1 |
20030004436 | Schmidt et al. | Jan 2003 | A1 |
20030032931 | Grundke et al. | Feb 2003 | A1 |
20030032944 | Cawood | Feb 2003 | A1 |
20030073964 | Palumbo et al. | Apr 2003 | A1 |
20030120178 | Heki | Jun 2003 | A1 |
20030157859 | Ishikawa | Aug 2003 | A1 |
20030181880 | Schwartz | Sep 2003 | A1 |
20030195484 | Harvie | Oct 2003 | A1 |
20030204173 | Burns et al. | Oct 2003 | A1 |
20030233079 | Parks et al. | Dec 2003 | A1 |
20040006321 | Cheng et al. | Jan 2004 | A1 |
20040015141 | Cheng et al. | Jan 2004 | A1 |
20040056122 | Male et al. | Mar 2004 | A1 |
20040084465 | Luburic | May 2004 | A1 |
20040127872 | Petryk et al. | Jul 2004 | A1 |
20040128749 | Scott | Jul 2004 | A1 |
20040143229 | Easter | Jul 2004 | A1 |
20040147863 | Diaz et al. | Jul 2004 | A1 |
20040147894 | Mizutani et al. | Jul 2004 | A1 |
20040158221 | Mizutani et al. | Aug 2004 | A1 |
20040176731 | Cheng et al. | Sep 2004 | A1 |
20040176746 | Forral | Sep 2004 | A1 |
20040191919 | Unger et al. | Sep 2004 | A1 |
20040207530 | Nielsen | Oct 2004 | A1 |
20040236292 | Tazoe | Nov 2004 | A1 |
20040243075 | Harvie | Dec 2004 | A1 |
20040254547 | Okabe et al. | Dec 2004 | A1 |
20050010182 | Parks et al. | Jan 2005 | A1 |
20050033248 | Machida et al. | Feb 2005 | A1 |
20050065471 | Kuntz | Mar 2005 | A1 |
20050070861 | Okabe et al. | Mar 2005 | A1 |
20050070862 | Tazoe et al. | Mar 2005 | A1 |
20050082300 | Modrell et al. | Apr 2005 | A1 |
20050097662 | Leimkuhler et al. | May 2005 | A1 |
20050101924 | Elson et al. | May 2005 | A1 |
20050119630 | Harvie | Jun 2005 | A1 |
20050137557 | Swiecicki et al. | Jun 2005 | A1 |
20050154360 | Harvie | Jul 2005 | A1 |
20050177070 | Levinson et al. | Aug 2005 | A1 |
20050197639 | Mombrinie | Sep 2005 | A1 |
20050273920 | Marinas | Dec 2005 | A1 |
20050277904 | Chase et al. | Dec 2005 | A1 |
20050279359 | Leblanc et al. | Dec 2005 | A1 |
20060004332 | Marx | Jan 2006 | A1 |
20060015080 | Mahnensmith | Jan 2006 | A1 |
20060015081 | Suzuki et al. | Jan 2006 | A1 |
20060016778 | Park | Jan 2006 | A1 |
20060069359 | Dipalma et al. | Mar 2006 | A1 |
20060079854 | Kay et al. | Apr 2006 | A1 |
20060111648 | Vermaak | May 2006 | A1 |
20060155214 | Wightman | Jul 2006 | A1 |
20060171997 | Gruenbacher et al. | Aug 2006 | A1 |
20060200102 | Cooper | Sep 2006 | A1 |
20060229575 | Boiarski | Oct 2006 | A1 |
20060229576 | Conway et al. | Oct 2006 | A1 |
20060231648 | Male et al. | Oct 2006 | A1 |
20060235266 | Nan | Oct 2006 | A1 |
20060235359 | Marland | Oct 2006 | A1 |
20060241553 | Harvie | Oct 2006 | A1 |
20060269439 | White | Nov 2006 | A1 |
20060277670 | Baker et al. | Dec 2006 | A1 |
20070006368 | Key et al. | Jan 2007 | A1 |
20070010797 | Nishtala et al. | Jan 2007 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070038194 | Wada et al. | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070073252 | Forgrave | Mar 2007 | A1 |
20070117880 | Elson et al. | May 2007 | A1 |
20070118993 | Bates | May 2007 | A1 |
20070135786 | Schmidt et al. | Jun 2007 | A1 |
20070137718 | Rushlander et al. | Jun 2007 | A1 |
20070149935 | Dirico | Jun 2007 | A1 |
20070191804 | Coley | Aug 2007 | A1 |
20070214553 | Carromba et al. | Sep 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070225666 | Otto | Sep 2007 | A1 |
20070225668 | Otto | Sep 2007 | A1 |
20070266486 | Ramirez | Nov 2007 | A1 |
20070282309 | Bengtson et al. | Dec 2007 | A1 |
20080004576 | Tanaka et al. | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080015527 | House | Jan 2008 | A1 |
20080033386 | Okabe et al. | Feb 2008 | A1 |
20080041869 | Backaert | Feb 2008 | A1 |
20080091153 | Harvie | Apr 2008 | A1 |
20080091158 | Yang | Apr 2008 | A1 |
20080114327 | Barge | May 2008 | A1 |
20080167634 | Kouta et al. | Jul 2008 | A1 |
20080183157 | Walters | Jul 2008 | A1 |
20080215031 | Belfort et al. | Sep 2008 | A1 |
20080234642 | Patterson et al. | Sep 2008 | A1 |
20080269703 | Collins et al. | Oct 2008 | A1 |
20080281282 | Finger et al. | Nov 2008 | A1 |
20080287894 | Van Den Heuvel | Nov 2008 | A1 |
20080312550 | Nishtala et al. | Dec 2008 | A1 |
20090025717 | Pinel | Jan 2009 | A1 |
20090048570 | Jensen | Feb 2009 | A1 |
20090056003 | Ivie et al. | Mar 2009 | A1 |
20090069761 | Vogel | Mar 2009 | A1 |
20090069765 | Wortham | Mar 2009 | A1 |
20090192482 | Dodge et al. | Jul 2009 | A1 |
20090234312 | Otoole et al. | Sep 2009 | A1 |
20090251510 | Noro et al. | Oct 2009 | A1 |
20090264840 | Virginio | Oct 2009 | A1 |
20090270822 | Medeiros | Oct 2009 | A1 |
20090281510 | Fisher | Nov 2009 | A1 |
20100004612 | Thevenin | Jan 2010 | A1 |
20100058660 | Williams | Mar 2010 | A1 |
20100121289 | Parks et al. | May 2010 | A1 |
20100158168 | Murthy et al. | Jun 2010 | A1 |
20100160882 | Lowe | Jun 2010 | A1 |
20100174250 | Hu et al. | Jul 2010 | A1 |
20100185168 | Graauw et al. | Jul 2010 | A1 |
20100198172 | Wada et al. | Aug 2010 | A1 |
20100211032 | Tsai et al. | Aug 2010 | A1 |
20100234820 | Tsai et al. | Sep 2010 | A1 |
20100241104 | Gilbert | Sep 2010 | A1 |
20100263113 | Shelton | Oct 2010 | A1 |
20100310845 | Bond et al. | Dec 2010 | A1 |
20110028920 | Johannison | Feb 2011 | A1 |
20110028922 | Kay et al. | Feb 2011 | A1 |
20110034889 | Smith | Feb 2011 | A1 |
20110036837 | Shang | Feb 2011 | A1 |
20110040267 | Wada et al. | Feb 2011 | A1 |
20110040271 | Rogers et al. | Feb 2011 | A1 |
20110054426 | Stewart et al. | Mar 2011 | A1 |
20110060299 | Wada et al. | Mar 2011 | A1 |
20110060300 | Weig et al. | Mar 2011 | A1 |
20110077495 | Gilbert | Mar 2011 | A1 |
20110077606 | Wilcox | Mar 2011 | A1 |
20110087337 | Forsell | Apr 2011 | A1 |
20110137273 | Muellejans et al. | Jun 2011 | A1 |
20110145993 | Rader et al. | Jun 2011 | A1 |
20110152802 | Dicamillo et al. | Jun 2011 | A1 |
20110164147 | Takahashi et al. | Jul 2011 | A1 |
20110172620 | Khambatta | Jul 2011 | A1 |
20110172625 | Wada et al. | Jul 2011 | A1 |
20110202024 | Cozzens | Aug 2011 | A1 |
20110238023 | Slayton | Sep 2011 | A1 |
20110240648 | Tucker | Oct 2011 | A1 |
20110251572 | Nishtala et al. | Oct 2011 | A1 |
20110265889 | Tanaka et al. | Nov 2011 | A1 |
20110276020 | Mitsui | Nov 2011 | A1 |
20120035577 | Tomes Dietz | Feb 2012 | A1 |
20120041400 | Christensen | Feb 2012 | A1 |
20120059328 | Dikeman et al. | Mar 2012 | A1 |
20120066825 | Birbara et al. | Mar 2012 | A1 |
20120103347 | Wheaton et al. | May 2012 | A1 |
20120137420 | Gordon et al. | Jun 2012 | A1 |
20120165768 | Sekiyama et al. | Jun 2012 | A1 |
20120165786 | Chappa et al. | Jun 2012 | A1 |
20120210503 | Anzivino et al. | Aug 2012 | A1 |
20120233761 | Huang | Sep 2012 | A1 |
20120245541 | Suzuki et al. | Sep 2012 | A1 |
20120245542 | Suzuki et al. | Sep 2012 | A1 |
20120245547 | Wilcox | Sep 2012 | A1 |
20120253303 | Suzuki et al. | Oct 2012 | A1 |
20120271259 | Ulert | Oct 2012 | A1 |
20120296305 | Barraza Khaled et al. | Nov 2012 | A1 |
20120316522 | Carter et al. | Dec 2012 | A1 |
20120330256 | Wilcox et al. | Dec 2012 | A1 |
20130006206 | Wada et al. | Jan 2013 | A1 |
20130045651 | Esteves et al. | Feb 2013 | A1 |
20130053804 | Soerensen et al. | Feb 2013 | A1 |
20130096523 | Chang et al. | Apr 2013 | A1 |
20130138064 | Stroebech et al. | May 2013 | A1 |
20130150813 | Gordon et al. | Jun 2013 | A1 |
20130245496 | Wells et al. | Sep 2013 | A1 |
20130245586 | Jha | Sep 2013 | A1 |
20130292537 | Dirico | Nov 2013 | A1 |
20130330501 | Aizenberg et al. | Dec 2013 | A1 |
20140005647 | Shuffler et al. | Jan 2014 | A1 |
20140031774 | Bengtson | Jan 2014 | A1 |
20140039432 | Dunbar et al. | Feb 2014 | A1 |
20140157499 | Suzuki et al. | Jun 2014 | A1 |
20140171889 | Hopman et al. | Jun 2014 | A1 |
20140182051 | Tanimoto et al. | Jul 2014 | A1 |
20140196189 | Lee et al. | Jul 2014 | A1 |
20140276501 | Cisko | Sep 2014 | A1 |
20140303582 | Wright et al. | Oct 2014 | A1 |
20140316381 | Reglin | Oct 2014 | A1 |
20140325746 | Block | Nov 2014 | A1 |
20140348139 | Gomez Martinez | Nov 2014 | A1 |
20140352050 | Yao et al. | Dec 2014 | A1 |
20140371628 | Desai | Dec 2014 | A1 |
20150045757 | Lee et al. | Feb 2015 | A1 |
20150047114 | Ramirez | Feb 2015 | A1 |
20150048089 | Robertson | Feb 2015 | A1 |
20150135423 | Sharpe et al. | May 2015 | A1 |
20150157300 | Ealovega et al. | Jun 2015 | A1 |
20150209194 | Heyman | Jul 2015 | A1 |
20150290425 | Macy et al. | Oct 2015 | A1 |
20150320583 | Harvie | Nov 2015 | A1 |
20150329255 | Rzepecki | Nov 2015 | A1 |
20150342799 | Michiels et al. | Dec 2015 | A1 |
20150359660 | Harvie | Dec 2015 | A1 |
20150366699 | Nelson | Dec 2015 | A1 |
20160029998 | Brister et al. | Feb 2016 | A1 |
20160030228 | Jones | Feb 2016 | A1 |
20160038356 | Yao et al. | Feb 2016 | A1 |
20160058322 | Brister et al. | Mar 2016 | A1 |
20160060001 | Wada et al. | Mar 2016 | A1 |
20160100976 | Conway et al. | Apr 2016 | A1 |
20160106604 | Timm | Apr 2016 | A1 |
20160113809 | Kim | Apr 2016 | A1 |
20160183689 | Miner | Jun 2016 | A1 |
20160256022 | Le | Sep 2016 | A1 |
20160270982 | Raycheck et al. | Sep 2016 | A1 |
20160278662 | Brister et al. | Sep 2016 | A1 |
20160357400 | Penha et al. | Dec 2016 | A1 |
20160366699 | Zhang et al. | Dec 2016 | A1 |
20160367226 | Newton et al. | Dec 2016 | A1 |
20160367411 | Justiz et al. | Dec 2016 | A1 |
20160374848 | Sanchez | Dec 2016 | A1 |
20170007438 | Harvie | Jan 2017 | A1 |
20170014560 | Minskoff et al. | Jan 2017 | A1 |
20170100276 | Joh | Apr 2017 | A1 |
20170128638 | Giezendanner et al. | May 2017 | A1 |
20170143534 | Sanchez | May 2017 | A1 |
20170165405 | Muser et al. | Jun 2017 | A1 |
20170189225 | Voorhees et al. | Jul 2017 | A1 |
20170202692 | Laniado | Jul 2017 | A1 |
20170216081 | Accosta | Aug 2017 | A1 |
20170246026 | Laniado | Aug 2017 | A1 |
20170252014 | Siller Gonzalez et al. | Sep 2017 | A1 |
20170252202 | Sanchez et al. | Sep 2017 | A9 |
20170266031 | Sanchez et al. | Sep 2017 | A1 |
20170266658 | Bruno et al. | Sep 2017 | A1 |
20170281399 | Vanmiddendorp et al. | Oct 2017 | A1 |
20170312116 | Laniado | Nov 2017 | A1 |
20170325788 | Ealovega et al. | Nov 2017 | A1 |
20170333244 | Laniado | Nov 2017 | A1 |
20170042748 | Griffin | Dec 2017 | A1 |
20170348139 | Newton et al. | Dec 2017 | A1 |
20170354532 | Holt | Dec 2017 | A1 |
20170354551 | Gawley et al. | Dec 2017 | A1 |
20170367873 | Grannum | Dec 2017 | A1 |
20180002075 | Lee | Jan 2018 | A1 |
20180008451 | Stroebech | Jan 2018 | A1 |
20180008804 | Laniado | Jan 2018 | A1 |
20180021218 | Brosch et al. | Jan 2018 | A1 |
20180028349 | Newton et al. | Feb 2018 | A1 |
20180037384 | Archeny et al. | Feb 2018 | A1 |
20180049910 | Newton | Feb 2018 | A1 |
20180064572 | Wiltshire | Mar 2018 | A1 |
20180104131 | Killian | Apr 2018 | A1 |
20180127187 | Sewell | May 2018 | A1 |
20180193215 | Davies et al. | Jul 2018 | A1 |
20180200101 | Su | Jul 2018 | A1 |
20180228642 | Davis et al. | Aug 2018 | A1 |
20180256384 | Kasirye | Sep 2018 | A1 |
20180271694 | Fernandez et al. | Sep 2018 | A1 |
20180317892 | Catlin | Nov 2018 | A1 |
20190001030 | Braga et al. | Jan 2019 | A1 |
20190021899 | Vlet | Jan 2019 | A1 |
20190038451 | Harvie | Feb 2019 | A1 |
20190046102 | Kushnir et al. | Feb 2019 | A1 |
20190100362 | Meyers et al. | Apr 2019 | A1 |
20190133814 | Tammen et al. | May 2019 | A1 |
20190142624 | Sanchez et al. | May 2019 | A1 |
20190224036 | Sanchez et al. | Jul 2019 | A1 |
20190247222 | Ecklund et al. | Aug 2019 | A1 |
20190247223 | Brun et al. | Aug 2019 | A1 |
20190282391 | Johannes et al. | Sep 2019 | A1 |
20190314189 | Acosta | Oct 2019 | A1 |
20190314190 | Sanchez et al. | Oct 2019 | A1 |
20190321587 | Mcmenamin et al. | Oct 2019 | A1 |
20190344934 | Faerber et al. | Nov 2019 | A1 |
20190365307 | Laing et al. | Dec 2019 | A1 |
20190365561 | Newton et al. | Dec 2019 | A1 |
20200008985 | Nguyen et al. | Jan 2020 | A1 |
20200016012 | Dutkiewicz | Jan 2020 | A1 |
20200030595 | Boukidjian et al. | Jan 2020 | A1 |
20200046544 | Godinez et al. | Feb 2020 | A1 |
20200055638 | Lau et al. | Feb 2020 | A1 |
20200070392 | Huber et al. | Mar 2020 | A1 |
20200085609 | Schelch et al. | Mar 2020 | A1 |
20200085610 | Cohn et al. | Mar 2020 | A1 |
20200086090 | Von Weymarn-Schärli et al. | Mar 2020 | A1 |
20200107518 | Hiroshima et al. | Apr 2020 | A1 |
20200129322 | Leuckel | Apr 2020 | A1 |
20200171217 | Braga et al. | Jun 2020 | A9 |
20200206039 | McLain | Jul 2020 | A1 |
20200214910 | Varona et al. | Jul 2020 | A1 |
20200216898 | Hubbell | Jul 2020 | A1 |
20200216989 | Kinugasa et al. | Jul 2020 | A1 |
20200229964 | Staali | Jul 2020 | A1 |
20200231343 | Freedman et al. | Jul 2020 | A1 |
20200232841 | Satish et al. | Jul 2020 | A1 |
20200246172 | Ho | Aug 2020 | A1 |
20200246203 | Tulk et al. | Aug 2020 | A1 |
20200255189 | Liu | Aug 2020 | A1 |
20200261280 | Heyman | Aug 2020 | A1 |
20200276046 | Staali et al. | Sep 2020 | A1 |
20200306075 | Newton et al. | Oct 2020 | A1 |
20200315837 | Radl et al. | Oct 2020 | A1 |
20200315838 | Eckert | Oct 2020 | A1 |
20200315872 | Viens et al. | Oct 2020 | A1 |
20200315874 | Viens et al. | Oct 2020 | A1 |
20200331672 | Bertram et al. | Oct 2020 | A1 |
20200345332 | Duval | Nov 2020 | A1 |
20200353135 | Gregory et al. | Nov 2020 | A1 |
20200367677 | Silsby et al. | Nov 2020 | A1 |
20200369444 | Silsby et al. | Nov 2020 | A1 |
20200375781 | Staali et al. | Dec 2020 | A1 |
20200375810 | Carlin et al. | Dec 2020 | A1 |
20200385179 | Mccourt | Dec 2020 | A1 |
20200390591 | Glithero et al. | Dec 2020 | A1 |
20200390592 | Merrill | Dec 2020 | A1 |
20200405521 | Glasroe | Dec 2020 | A1 |
20210008771 | Huber et al. | Jan 2021 | A1 |
20210009323 | Markarian et al. | Jan 2021 | A1 |
20210020072 | Moehring et al. | Jan 2021 | A1 |
20210059853 | Davis et al. | Mar 2021 | A1 |
20210061523 | Bytheway | Mar 2021 | A1 |
20210069005 | Sanchez et al. | Mar 2021 | A1 |
20210069008 | Blabas et al. | Mar 2021 | A1 |
20210069009 | Im | Mar 2021 | A1 |
20210069030 | Nishikawa et al. | Mar 2021 | A1 |
20210077993 | Nazareth et al. | Mar 2021 | A1 |
20210113749 | Radl et al. | Apr 2021 | A1 |
20210121318 | Pinlac | Apr 2021 | A1 |
20210137724 | Ecklund et al. | May 2021 | A1 |
20210138190 | Erbey et al. | May 2021 | A1 |
20210154055 | Mllarreal | May 2021 | A1 |
20210170079 | Radl et al. | Jun 2021 | A1 |
20210178390 | Oueslati et al. | Jun 2021 | A1 |
20210186742 | Newton et al. | Jun 2021 | A1 |
20210212865 | Wallajapet et al. | Jul 2021 | A1 |
20210220162 | Jamison | Jul 2021 | A1 |
20210220163 | Mayrand | Jul 2021 | A1 |
20210228400 | Glithero | Jul 2021 | A1 |
20210228401 | Becker et al. | Jul 2021 | A1 |
20210228795 | Hughett et al. | Jul 2021 | A1 |
20210229877 | Ragias et al. | Jul 2021 | A1 |
20210236323 | Austermann et al. | Aug 2021 | A1 |
20210236324 | Sweeney | Aug 2021 | A1 |
20210251814 | Jönegren et al. | Aug 2021 | A1 |
20210267787 | Nazemi | Sep 2021 | A1 |
20210275343 | Sanchez et al. | Sep 2021 | A1 |
20210290454 | Yamada | Sep 2021 | A1 |
20210315727 | Jiang | Oct 2021 | A1 |
20210353450 | Sharma et al. | Nov 2021 | A1 |
20210361469 | Liu et al. | Nov 2021 | A1 |
20210369495 | Cheng et al. | Dec 2021 | A1 |
20210386925 | Hartwell et al. | Dec 2021 | A1 |
20210393433 | Godinez et al. | Dec 2021 | A1 |
20220023091 | Ecklund et al. | Jan 2022 | A1 |
20220031523 | Pierpoint | Feb 2022 | A1 |
20220039995 | Johannes et al. | Feb 2022 | A1 |
20220047410 | Walthall | Feb 2022 | A1 |
20220062027 | Mitchell et al. | Mar 2022 | A1 |
20220062028 | Mitchell et al. | Mar 2022 | A1 |
20220062029 | Johannes et al. | Mar 2022 | A1 |
20220066825 | Saraf et al. | Mar 2022 | A1 |
20220071811 | Cheng et al. | Mar 2022 | A1 |
20220071826 | Kulkarni et al. | Mar 2022 | A1 |
20220104965 | Vaninetti et al. | Apr 2022 | A1 |
20220104976 | Hoeger et al. | Apr 2022 | A1 |
20220104981 | Jones | Apr 2022 | A1 |
20220117773 | Davis et al. | Apr 2022 | A1 |
20220117774 | Meyer et al. | Apr 2022 | A1 |
20220117775 | Jones et al. | Apr 2022 | A1 |
20220133524 | Davis | May 2022 | A1 |
20220151817 | Mann | May 2022 | A1 |
20220160949 | Simiele et al. | May 2022 | A1 |
20220168159 | Triado et al. | Jun 2022 | A1 |
20220193312 | Lee et al. | Jun 2022 | A1 |
20220211536 | Johannes et al. | Jul 2022 | A1 |
20220218510 | Metzger et al. | Jul 2022 | A1 |
20220229053 | Levin et al. | Jul 2022 | A1 |
20220241106 | Johannes et al. | Aug 2022 | A1 |
20220247407 | Yamamoto et al. | Aug 2022 | A1 |
20220248836 | Cagle et al. | Aug 2022 | A1 |
20220257407 | Johannes et al. | Aug 2022 | A1 |
20220265460 | Coker | Aug 2022 | A1 |
20220265462 | Alder et al. | Aug 2022 | A1 |
20220270711 | Feala et al. | Aug 2022 | A1 |
20220273482 | Johannes et al. | Sep 2022 | A1 |
20220280357 | Jagannathan et al. | Sep 2022 | A1 |
20220287689 | Johannes | Sep 2022 | A1 |
20220296408 | Evans et al. | Sep 2022 | A1 |
20220305191 | Joseph et al. | Sep 2022 | A1 |
20220313222 | Austermann et al. | Oct 2022 | A1 |
20220313474 | Kriscovich et al. | Oct 2022 | A1 |
20220331170 | Erdem et al. | Oct 2022 | A1 |
20220339024 | Johannes et al. | Oct 2022 | A1 |
20220354685 | Davis et al. | Nov 2022 | A1 |
20220362049 | Austermann et al. | Nov 2022 | A1 |
20220370231 | Wang et al. | Nov 2022 | A1 |
20220370234 | Hughett et al. | Nov 2022 | A1 |
20220370235 | Johannes et al. | Nov 2022 | A1 |
20220370237 | Parmar et al. | Nov 2022 | A1 |
20220387001 | Askenazi et al. | Dec 2022 | A1 |
20220395390 | Brooks | Dec 2022 | A1 |
20220395391 | Saunders et al. | Dec 2022 | A1 |
20230018845 | Lee | Jan 2023 | A1 |
20230020563 | Sharma et al. | Jan 2023 | A1 |
20230031640 | Hughett, Sr. | Feb 2023 | A1 |
20230037159 | Brennan | Feb 2023 | A1 |
20230052238 | Oluwasogo | Feb 2023 | A1 |
20230062944 | Vollenberg et al. | Mar 2023 | A1 |
20230062994 | Ecklund et al. | Mar 2023 | A1 |
20230070347 | Watson et al. | Mar 2023 | A1 |
20230073708 | Xu et al. | Mar 2023 | A1 |
20230089032 | Hughett | Mar 2023 | A1 |
20230099821 | Radl et al. | Mar 2023 | A1 |
20230099991 | Bianchi et al. | Mar 2023 | A1 |
20230105001 | Whittome et al. | Apr 2023 | A1 |
20230110577 | Choi | Apr 2023 | A1 |
20230138269 | Abdelal et al. | May 2023 | A1 |
20230145365 | Martin et al. | May 2023 | A1 |
20230155253 | Yin et al. | May 2023 | A1 |
20230210504 | Kuroda et al. | Jul 2023 | A1 |
20230218426 | Hughett | Jul 2023 | A1 |
20230248562 | Sanchez et al. | Aug 2023 | A1 |
20230255812 | Sanchez et al. | Aug 2023 | A1 |
20230255813 | Sanchez et al. | Aug 2023 | A1 |
20230255815 | Newton | Aug 2023 | A1 |
20230263650 | Sanchez et al. | Aug 2023 | A1 |
20230263655 | Johannes et al. | Aug 2023 | A1 |
20230277362 | Davis et al. | Sep 2023 | A1 |
20230285178 | Sanchez et al. | Sep 2023 | A1 |
20230293339 | James | Sep 2023 | A1 |
20230301846 | Greenwood | Sep 2023 | A1 |
20230355423 | Stevenson et al. | Nov 2023 | A1 |
20230404791 | Ecklund et al. | Dec 2023 | A1 |
20240008444 | Su et al. | Jan 2024 | A1 |
20240009023 | Johannes et al. | Jan 2024 | A1 |
20240024170 | Scott | Jan 2024 | A1 |
20240041638 | Johannes et al. | Feb 2024 | A1 |
20240058161 | Ulreich et al. | Feb 2024 | A1 |
20240065881 | Kuroda et al. | Feb 2024 | A1 |
20240099874 | Sanchez et al. | Mar 2024 | A1 |
20240110318 | Bendt et al. | Apr 2024 | A1 |
Number | Date | Country |
---|---|---|
2018216821 | Aug 2019 | AU |
2021299304 | Feb 2023 | AU |
2165286 | Sep 1999 | CA |
2354132 | Jun 2000 | CA |
2488867 | Aug 2007 | CA |
3050918 | Aug 2018 | CA |
3098571 | Nov 2019 | CA |
2269203 | Dec 1997 | CN |
1332620 | Jan 2002 | CN |
1533755 | Oct 2004 | CN |
1602825 | Apr 2005 | CN |
1720888 | Jan 2006 | CN |
2936204 | Aug 2007 | CN |
101262836 | Sep 2008 | CN |
101522148 | Sep 2009 | CN |
102159159 | Aug 2011 | CN |
202184840 | Apr 2012 | CN |
102481441 | May 2012 | CN |
202463712 | Oct 2012 | CN |
103533968 | Jan 2014 | CN |
103717180 | Apr 2014 | CN |
204562697 | Aug 2015 | CN |
105411783 | Mar 2016 | CN |
105451693 | Mar 2016 | CN |
105534632 | May 2016 | CN |
205849719 | Jan 2017 | CN |
106726089 | May 2017 | CN |
107847384 | Mar 2018 | CN |
107920912 | Apr 2018 | CN |
209285902 | Aug 2019 | CN |
110381883 | Oct 2019 | CN |
211198839 | Aug 2020 | CN |
112566550 | Mar 2021 | CN |
112603184 | Apr 2021 | CN |
114007493 | Feb 2022 | CN |
114375187 | Apr 2022 | CN |
79818 | Oct 1893 | DE |
1516466 | Jun 1969 | DE |
2721330 | Nov 1977 | DE |
2742298 | Mar 1978 | DE |
9407554.9 | May 1995 | DE |
4443710 | Jun 1995 | DE |
4416094 | Nov 1995 | DE |
4236097 | Oct 1996 | DE |
19619597 | Nov 1997 | DE |
102005037762 | Sep 2006 | DE |
102011103783 | Dec 2012 | DE |
202015104597 | Jul 2016 | DE |
9600118 | Nov 1996 | DK |
0032138 | Jul 1981 | EP |
0066070 | Dec 1982 | EP |
0140470 | May 1985 | EP |
0140471 | May 1988 | EP |
0274753 | Jul 1988 | EP |
0119143 | Nov 1988 | EP |
0483592 | May 1992 | EP |
0610638 | Aug 1994 | EP |
0613355 | Sep 1994 | EP |
0613355 | Jan 1997 | EP |
0787472 | Aug 1997 | EP |
0966936 | Dec 1999 | EP |
0987293 | Mar 2000 | EP |
1063953 | Jan 2001 | EP |
0653928 | Oct 2002 | EP |
1332738 | Aug 2003 | EP |
1382318 | Jan 2004 | EP |
1089684 | Oct 2004 | EP |
1616542 | Jan 2006 | EP |
1382318 | May 2006 | EP |
1063953 | Jan 2007 | EP |
1872752 | Jan 2008 | EP |
2180907 | May 2010 | EP |
2380532 | Oct 2011 | EP |
2389908 | Nov 2011 | EP |
2601916 | Jun 2013 | EP |
2676643 | Dec 2013 | EP |
2997950 | Mar 2016 | EP |
2879534 | Mar 2017 | EP |
3424471 | Jan 2019 | EP |
3169292 | Nov 2019 | EP |
3753492 | Dec 2020 | EP |
3788992 | Mar 2021 | EP |
3576689 | Mar 2022 | EP |
3752110 | Mar 2022 | EP |
3787570 | Mar 2022 | EP |
4025163 | Jul 2022 | EP |
3463180 | Mar 2023 | EP |
1011517 | Dec 1965 | GB |
1467144 | Mar 1977 | GB |
2106395 | Apr 1983 | GB |
2106784 | Apr 1983 | GB |
2148126 | May 1985 | GB |
2171315 | Aug 1986 | GB |
2181953 | May 1987 | GB |
2148126 | Jul 1987 | GB |
2191095 | Dec 1987 | GB |
2199750 | Jul 1988 | GB |
2260907 | May 1993 | GB |
2462267 | Feb 2010 | GB |
2469496 | Oct 2010 | GB |
2490327 | Oct 2012 | GB |
2507318 | Apr 2014 | GB |
2612752 | May 2023 | GB |
201800009129 | Apr 2020 | IT |
S5410596 | Jan 1979 | JP |
S5410596 | May 1979 | JP |
S55155618 | Dec 1980 | JP |
S5888596 | Jun 1983 | JP |
S63107780 | Jul 1988 | JP |
H0267530 | Mar 1990 | JP |
H02103871 | Apr 1990 | JP |
H02131422 | May 1990 | JP |
H02131422 | Nov 1990 | JP |
H0460220 | Feb 1992 | JP |
H05123349 | May 1993 | JP |
H05123350 | May 1993 | JP |
3087938 | Oct 1995 | JP |
H085630 | Jan 1996 | JP |
H1040141 | Feb 1998 | JP |
H10225430 | Aug 1998 | JP |
H11113946 | Apr 1999 | JP |
H11290365 | Oct 1999 | JP |
2000116690 | Apr 2000 | JP |
2000185068 | Jul 2000 | JP |
2001054531 | Feb 2001 | JP |
2001070331 | Mar 2001 | JP |
2001224616 | Aug 2001 | JP |
2001276107 | Oct 2001 | JP |
2001276108 | Oct 2001 | JP |
2002028173 | Jan 2002 | JP |
2003505152 | Feb 2003 | JP |
2003180722 | Jul 2003 | JP |
2004130056 | Apr 2004 | JP |
2004267530 | Sep 2004 | JP |
2005066011 | Mar 2005 | JP |
2005066325 | Mar 2005 | JP |
2005518237 | Jun 2005 | JP |
3749097 | Dec 2005 | JP |
2006026108 | Feb 2006 | JP |
3123547 | Jun 2006 | JP |
2006136492 | Jun 2006 | JP |
2006204868 | Aug 2006 | JP |
2007044494 | Feb 2007 | JP |
3132659 | May 2007 | JP |
4039641 | Nov 2007 | JP |
2009509570 | Mar 2009 | JP |
2010081981 | Apr 2010 | JP |
4640772 | Dec 2010 | JP |
2010536439 | Dec 2010 | JP |
4747166 | May 2011 | JP |
2011087823 | May 2011 | JP |
4801218 | Aug 2011 | JP |
2011218130 | Nov 2011 | JP |
2011224070 | Nov 2011 | JP |
2012523869 | Oct 2012 | JP |
2013238608 | Nov 2013 | JP |
2014521960 | Aug 2014 | JP |
2015092945 | May 2015 | JP |
3198994 | Jul 2015 | JP |
2019525811 | Sep 2019 | JP |
2021120686 | Aug 2021 | JP |
2021522009 | Aug 2021 | JP |
7129493 | Aug 2022 | JP |
2023532132 | Jul 2023 | JP |
200290061 | Sep 2002 | KR |
20030047451 | Jun 2003 | KR |
20140039485 | Apr 2014 | KR |
101432639 | Aug 2014 | KR |
20180106659 | Oct 2018 | KR |
20180108774 | Oct 2018 | KR |
2068717 | Jun 2013 | PT |
8101957 | Jul 1981 | WO |
8804558 | Jun 1988 | WO |
9104714 | Apr 1991 | WO |
9104714 | Jun 1991 | WO |
9220299 | Feb 1993 | WO |
9307839 | Apr 1993 | WO |
9309736 | May 1993 | WO |
9309736 | Jun 1993 | WO |
9514448 | Jun 1995 | WO |
9600096 | Jan 1996 | WO |
9634636 | Nov 1996 | WO |
9817211 | Apr 1998 | WO |
9830336 | Jul 1998 | WO |
0000112 | Jan 2000 | WO |
0000113 | Jan 2000 | WO |
0025651 | May 2000 | WO |
0033773 | Jun 2000 | WO |
0057784 | Oct 2000 | WO |
0069377 | Nov 2000 | WO |
0079497 | Dec 2000 | WO |
0145618 | Jun 2001 | WO |
0145621 | Jun 2001 | WO |
02094160 | Nov 2002 | WO |
03013967 | Feb 2003 | WO |
03024824 | Mar 2003 | WO |
03055423 | Jul 2003 | WO |
03071931 | Sep 2003 | WO |
03079942 | Oct 2003 | WO |
03071931 | Feb 2004 | WO |
2004019836 | Mar 2004 | WO |
2004024046 | Mar 2004 | WO |
2005051252 | Jun 2005 | WO |
2005074571 | Sep 2005 | WO |
2005089687 | Sep 2005 | WO |
2005107661 | Nov 2005 | WO |
2006021220 | Mar 2006 | WO |
2006037140 | Apr 2006 | WO |
2007005851 | Jan 2007 | WO |
2007007845 | Jan 2007 | WO |
2007042823 | Apr 2007 | WO |
2007055651 | May 2007 | WO |
2006098950 | Nov 2007 | WO |
2007134608 | Nov 2007 | WO |
2007128156 | Feb 2008 | WO |
2008026106 | Mar 2008 | WO |
2008078117 | Jul 2008 | WO |
2008104019 | Sep 2008 | WO |
2008141471 | Nov 2008 | WO |
2009004368 | Jan 2009 | WO |
2009004369 | Jan 2009 | WO |
2009052496 | Apr 2009 | WO |
2009052502 | Apr 2009 | WO |
2009007702 | Jul 2009 | WO |
2009101738 | Aug 2009 | WO |
2010058192 | May 2010 | WO |
2010030122 | Jul 2010 | WO |
2010101915 | Jan 2011 | WO |
2011018132 | Feb 2011 | WO |
2011018133 | Feb 2011 | WO |
2011024864 | Mar 2011 | WO |
2011054118 | May 2011 | WO |
2011079132 | Jun 2011 | WO |
2011107972 | Sep 2011 | WO |
2011108972 | Sep 2011 | WO |
2011117292 | Sep 2011 | WO |
2011123219 | Oct 2011 | WO |
2011132043 | Oct 2011 | WO |
2012012908 | Feb 2012 | WO |
2012065274 | May 2012 | WO |
2012097462 | Jul 2012 | WO |
2012098796 | Jul 2012 | WO |
2012101288 | Aug 2012 | WO |
2012175916 | Dec 2012 | WO |
2013018435 | Feb 2013 | WO |
2013033429 | Mar 2013 | WO |
2013055434 | Apr 2013 | WO |
2013082397 | Jun 2013 | WO |
2013103291 | Jul 2013 | WO |
2013131109 | Sep 2013 | WO |
2013167478 | Nov 2013 | WO |
2013177716 | Dec 2013 | WO |
2014041534 | Mar 2014 | WO |
2014046420 | Mar 2014 | WO |
2014118518 | Aug 2014 | WO |
2014160852 | Oct 2014 | WO |
2015023599 | Feb 2015 | WO |
2015052348 | Apr 2015 | WO |
2015068384 | May 2015 | WO |
2015169403 | Nov 2015 | WO |
2015170307 | Nov 2015 | WO |
2015197462 | Dec 2015 | WO |
2016051385 | Apr 2016 | WO |
2016055989 | Apr 2016 | WO |
2016071894 | May 2016 | WO |
2016103242 | Jun 2016 | WO |
2016116915 | Jul 2016 | WO |
2016124203 | Aug 2016 | WO |
2016139448 | Sep 2016 | WO |
2016166562 | Oct 2016 | WO |
2016167535 | Oct 2016 | WO |
2016191574 | Dec 2016 | WO |
2016200088 | Dec 2016 | WO |
2016200361 | Dec 2016 | WO |
2016204731 | Dec 2016 | WO |
2017001532 | Jan 2017 | WO |
2017001846 | Jan 2017 | WO |
2017075226 | May 2017 | WO |
2017152198 | Sep 2017 | WO |
2017153357 | Sep 2017 | WO |
2017162559 | Sep 2017 | WO |
2017205446 | Nov 2017 | WO |
2017209779 | Dec 2017 | WO |
2017210524 | Dec 2017 | WO |
2018022414 | Feb 2018 | WO |
2018044781 | Mar 2018 | WO |
2018056953 | Mar 2018 | WO |
2018090550 | May 2018 | WO |
2018138513 | Aug 2018 | WO |
2018144318 | Aug 2018 | WO |
2018144463 | Aug 2018 | WO |
2018150263 | Aug 2018 | WO |
2018150268 | Aug 2018 | WO |
2018152156 | Aug 2018 | WO |
2018183791 | Oct 2018 | WO |
2018150267 | Nov 2018 | WO |
2018235026 | Dec 2018 | WO |
2018235065 | Dec 2018 | WO |
2019004404 | Jan 2019 | WO |
2019041005 | Mar 2019 | WO |
2019044217 | Mar 2019 | WO |
2019044218 | Mar 2019 | WO |
2019044219 | Mar 2019 | WO |
2019065541 | Apr 2019 | WO |
2019096845 | May 2019 | WO |
2019150385 | Aug 2019 | WO |
2019161094 | Aug 2019 | WO |
2019188566 | Oct 2019 | WO |
2019190593 | Oct 2019 | WO |
2019212949 | Nov 2019 | WO |
2019212950 | Nov 2019 | WO |
2019212951 | Nov 2019 | WO |
2019212952 | Nov 2019 | WO |
2019212954 | Nov 2019 | WO |
2019212955 | Nov 2019 | WO |
2019212956 | Nov 2019 | WO |
2019214787 | Nov 2019 | WO |
2019214788 | Nov 2019 | WO |
2019226826 | Nov 2019 | WO |
WO-2019212955 | Nov 2019 | WO |
2019239433 | Dec 2019 | WO |
2020000994 | Jan 2020 | WO |
2020020618 | Jan 2020 | WO |
2020038822 | Feb 2020 | WO |
2020088409 | May 2020 | WO |
2020049394 | Jun 2020 | WO |
2020120657 | Jun 2020 | WO |
2020152575 | Jul 2020 | WO |
2020182923 | Sep 2020 | WO |
2020204967 | Oct 2020 | WO |
2020205939 | Oct 2020 | WO |
2020209898 | Oct 2020 | WO |
2020242790 | Dec 2020 | WO |
2020251893 | Dec 2020 | WO |
2020256865 | Dec 2020 | WO |
WO-2020242790 | Dec 2020 | WO |
2021007144 | Jan 2021 | WO |
2021007345 | Jan 2021 | WO |
2021010844 | Jan 2021 | WO |
2021016026 | Jan 2021 | WO |
2021016300 | Jan 2021 | WO |
2021025919 | Feb 2021 | WO |
2021034886 | Feb 2021 | WO |
WO-2021034886 | Feb 2021 | WO |
2021041123 | Mar 2021 | WO |
2021046501 | Mar 2021 | WO |
2021094352 | May 2021 | WO |
2021094639 | May 2021 | WO |
2021097067 | May 2021 | WO |
2021102296 | May 2021 | WO |
WO-2021086868 | May 2021 | WO |
2021107025 | Jun 2021 | WO |
2021138411 | Jul 2021 | WO |
2021138414 | Jul 2021 | WO |
2021154686 | Aug 2021 | WO |
2021155206 | Aug 2021 | WO |
2021170075 | Sep 2021 | WO |
2021173436 | Sep 2021 | WO |
2021188817 | Sep 2021 | WO |
2021195384 | Sep 2021 | WO |
WO-2021195384 | Sep 2021 | WO |
2021205995 | Oct 2021 | WO |
2021207621 | Oct 2021 | WO |
2021211568 | Oct 2021 | WO |
2021211801 | Oct 2021 | WO |
2021211914 | Oct 2021 | WO |
2021216419 | Oct 2021 | WO |
2021216422 | Oct 2021 | WO |
2021231532 | Nov 2021 | WO |
2021247523 | Dec 2021 | WO |
2021257202 | Dec 2021 | WO |
2022006256 | Jan 2022 | WO |
2022031943 | Feb 2022 | WO |
2022035745 | Feb 2022 | WO |
2022051360 | Mar 2022 | WO |
2022054613 | Mar 2022 | WO |
2022066704 | Mar 2022 | WO |
2022067392 | Apr 2022 | WO |
2022069950 | Apr 2022 | WO |
2022071429 | Apr 2022 | WO |
2022076322 | Apr 2022 | WO |
2022076427 | Apr 2022 | WO |
2022086898 | Apr 2022 | WO |
2022090199 | May 2022 | WO |
2022098536 | May 2022 | WO |
2022099087 | May 2022 | WO |
2022101999 | May 2022 | WO |
2022115692 | Jun 2022 | WO |
2022125685 | Jun 2022 | WO |
2022140545 | Jun 2022 | WO |
2022145231 | Jul 2022 | WO |
2022150360 | Jul 2022 | WO |
2022150463 | Jul 2022 | WO |
2022159392 | Jul 2022 | WO |
2022170182 | Aug 2022 | WO |
2022182385 | Sep 2022 | WO |
2022187152 | Sep 2022 | WO |
2022192188 | Sep 2022 | WO |
2022192347 | Sep 2022 | WO |
2022216507 | Oct 2022 | WO |
2022222030 | Oct 2022 | WO |
2023286058 | Jan 2023 | WO |
2023014639 | Feb 2023 | WO |
2023018475 | Feb 2023 | WO |
WO-2023014641 | Feb 2023 | WO |
2023023777 | Mar 2023 | WO |
2023034453 | Mar 2023 | WO |
2023038945 | Mar 2023 | WO |
2023049109 | Mar 2023 | WO |
2023049175 | Mar 2023 | WO |
2023086394 | May 2023 | WO |
2023149884 | Aug 2023 | WO |
2023149902 | Aug 2023 | WO |
2023149903 | Aug 2023 | WO |
2023154390 | Aug 2023 | WO |
2023191764 | Oct 2023 | WO |
2023244238 | Dec 2023 | WO |
2024058788 | Mar 2024 | WO |
Entry |
---|
US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn) |
Advisory Action for U.S. Appl. No. 17/444,792 mailed Aug. 25, 2023. |
Advisory Action for U.S. Appl. No. 16/245,726 mailed Apr. 19, 2023. |
Advisory Action for U.S. Appl. No. 16/369,676 mailed Mar. 24, 2023. |
Advisory Action for U.S. Appl. No. 16/433,773 mailed Feb. 15, 2023. |
Advisory Action for U.S. Appl. No. 16/452,258 mailed Oct. 26, 2022. |
Advisory Action for U.S. Application No. 16/478, 180 mailed Sep. 21, 2022. |
Advisory Action for U.S. Appl. No. 16/904,868 mailed Jun. 15, 2022. |
Advisory Action for U.S. Appl. No. 17/662,700 mailed Jan. 30, 2023. |
Final Office Action for U.S. Appl. No. 16/245,726 mailed Nov. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/369,676 mailed Dec. 5, 2022. |
Final Office Action for U.S. Appl. No. 16/433,773 mailed Oct. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/449,039 mailed Aug. 1, 2022. |
Final Office Action for U.S. Appl. No. 16/452,258 mailed Jun. 14, 2022. |
Final Office Action for U.S. Application No. 16/478, 180 mailed Jun. 22, 2022. |
Final Office Action for U.S. Application No. 16/478, 180 mailed May 31, 2023. |
Final Office Action for U.S. Appl. No. 17/051,399 mailed Mar. 9, 2023. |
Final Office Action for U.S. Appl. No. 17/051,550 mailed May 23, 2023. |
Final Office Action for U.S. Appl. No. 17/051,585 mailed Jul. 27, 2023. |
Final Office Action for U.S. Appl. No. 17/444,792 mailed Jun. 15, 2023. |
Final Office Action for U.S. Appl. No. 17/448,811 mailed Aug. 3, 2023. |
Final Office Action for U.S. Appl. No. 17/451,345 mailed May 3, 2023. |
Final Office Action for U.S. Appl. No. 17/662,700 mailed Sep. 30, 2022. |
International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 mailed Nov. 5, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/057562 mailed Jan. 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/026607 mailed Jul. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/039866 mailed Oct. 7, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/049404 mailed Jan. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/051456 mailed Jan. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/053593 mailed Apr. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/055515 mailed Jan. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/062440 mailed Mar. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011108 mailed Apr. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011281 mailed Apr. 25, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011419 mailed Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011421 mailed Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/012794 mailed May 3, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014285 mailed Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014749 mailed Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015026 mailed Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015045 mailed Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015073 mailed Sep. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015418 mailed Nov. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015420 mailed Nov. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015471 mailed May 16, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015492 mailed Apr. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015781 mailed May 6, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/016942 mailed Jun. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018159 mailed Dec. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018170 mailed May 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019254 mailed Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019480 mailed Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/021103 mailed Jun. 23, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/022111 mailed Oct. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/023594 mailed Jul. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/026667 mailed Aug. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/030685 mailed Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/031032 mailed Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/032424 mailed Oct. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034457 mailed Oct. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034744 mailed Dec. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039018 mailed Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039022 mailed Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039711 mailed Jan. 12, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039714 mailed Nov. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/041085 mailed Mar. 16, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/041688 mailed Nov. 21, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042719 mailed Dec. 5, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042725 mailed Dec. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/043818 mailed Mar. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044107 mailed Dec. 23, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044208 mailed May 8, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044212 mailed Jan. 20, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044243 mailed Feb. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/049300 mailed Jun. 6, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/050909 mailed Jul. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/012696 mailed Jul. 6, 2023. |
Issue Notification for U.S. Appl. No. 16/899,956 mailed Mar. 29, 2023. |
Issue Notification for U.S. Appl. No. 16/905,400 mailed Nov. 30, 2022. |
Issue Notification for U.S. Appl. No. 17/088,272 mailed Jun. 15, 2022. |
Issue Notification for U.S. Appl. No. 17/330,657 mailed Jun. 22, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/369,676 mailed Mar. 31, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Apr. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Apr. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 mailed Apr. 27, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Mar. 28, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 mailed Apr. 26, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Dec. 20, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 15, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Apr. 27, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/051,399 mailed Aug. 18, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,550 mailed Dec. 15, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/051,585 mailed Mar. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/179,116 mailed Mar. 24, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/326,980 mailed Jul. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/444,792 mailed Feb. 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,256 mailed Apr. 13, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/448,811 mailed Mar. 1, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/450,864 mailed May 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Dec. 7, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/451,354 mailed May 3, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/453,260 mailed Mar. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/501,591 mailed Apr. 25, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/646,771 mailed Jul. 5, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/653,137 mailed Apr. 7, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/655,464 mailed Mar. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/661,090 mailed Jul. 6, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/662,700 mailed Jul. 22, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/663,330 mailed Jun. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/664,487 mailed Jun. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/139,523 mailed Aug. 17, 2023. |
Notice of Allowance for U.S. Appl. No. 16/245,726 mailed Jul. 6, 2023. |
Notice of Allowance for U.S. Appl. No. 16/449,039 mailed Dec. 15, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Apr. 19, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Aug. 10, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Dec. 1, 2022. |
Notice of Allowance for U.S. Appl. No. 16/905,400 mailed Aug. 17, 2022. |
Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Jul. 6, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Feb. 22, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Jun. 30, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Oct. 6, 2022. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Jul. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Mar. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 17/663,046 mailed Jan. 30, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Jul. 24, 2023. |
Notice of Allowance for U.S. Appl. No. 29/741,751 mailed Jun. 9, 2022. |
Restriction Requirement for U.S. Appl. No. 17/326,980 mailed Mar. 20, 2023. |
Restriction Requirement for U.S. Appl. No. 17/446,256 mailed Jan. 23, 2023. |
Restriction Requirement for U.S. Appl. No. 17/646,771 mailed Apr. 6, 2023. |
Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022. |
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017. |
U.S. Appl. No. 15/612,325, filed Jun. 2, 2017. |
U.S. Appl. No. 17/661,090, filed Apr. 28, 2022. |
U.S. Appl. No. 17/662,700, filed May 10, 2022. |
U.S. Appl. No. 17/663,046, filed May 12, 2022. |
U.S. Appl. No. 17/664,487, filed May 23, 2022. |
U.S. Appl. No. 17/664,914, filed May 25, 2022. |
U.S. Appl. No. 17/749,340, filed May 20, 2022. |
U.S. Appl. No. 17/756,201, filed May 19, 2022. |
U.S. Appl. No. 17/758,152, filed Jun. 29, 2022. |
U.S. Appl. No. 17/758,316, filed Jul. 1, 2022. |
U.S. Appl. No. 17/759,697, filed Jul. 28, 2022. |
U.S. Appl. No. 17/878,268, filed Aug. 1, 2022. |
U.S. Appl. No. 17/907,125, filed Sep. 23, 2022. |
U.S. Appl. No. 17/912,147, filed Sep. 16, 2022. |
U.S. Appl. No. 17/929,887, filed Sep. 6, 2022. |
U.S. Appl. No. 17/930,238, filed Sep. 7, 2022. |
U.S. Appl. No. 17/933,590, filed Sep. 20, 2022. |
U.S. Appl. No. 17/996,064, filed Oct. 12, 2022. |
U.S. Appl. No. 17/996,155, filed Oct. 13, 2022. |
U.S. Appl. No. 17/996,253, filed Oct. 14, 2022. |
U.S. Appl. No. 17/996,468, filed Oct. 18, 2022. |
U.S. Appl. No. 17/996,556, filed Oct. 19, 2022. |
U.S. Appl. No. 18/003,029, filed Dec. 22, 2022. |
U.S. Appl. No. 18/006,807, filed Jan. 25, 2023. |
U.S. Appl. No. 18/007,105, filed Jan. 27, 2023. |
U.S. Appl. No. 18/041,109, filed Feb. 9, 2023. |
U.S. Appl. No. 18/042,842, filed Feb. 24, 2023. |
U.S. Appl. No. 18/043,618, filed Mar. 1, 2023. |
U.S. Appl. No. 18/115,444, filed Feb. 28, 2023. |
U.S. Appl. No. 18/134,857, filed Apr. 14, 2023. |
U.S. Appl. No. 18/140,163, filed Apr. 27, 2023. |
U.S. Appl. No. 18/140,751, filed Apr. 28, 2023. |
U.S. Appl. No. 18/164,800, filed Feb. 6, 2023. |
U.S. Appl. No. 18/198,464, filed May 17, 2023. |
U.S. Appl. No. 18/246,121, filed Mar. 21, 2023. |
U.S. Appl. No. 18/247,986, filed Apr. 5, 2023. |
U.S. Appl. No. 18/259,626, filed Jun. 28, 2023. |
U.S. Appl. No. 18/260,122, filed Jun. 30, 2023. |
U.S. Appl. No. 18/260,391, filed Jul. 5, 2023. |
U.S. Appl. No. 18/260,394, filed Jul. 5, 2023. |
U.S. Appl. No. 18/263,800, filed Aug. 1, 2023. |
U.S. Appl. No. 18/264,004, filed Aug. 2, 2023. |
U.S. Appl. No. 18/265,736, filed Jun. 7, 2023. |
U.S. Appl. No. 18/299,788, filed Apr. 13, 2023. |
U.S. Appl. No. 18/335,579, filed Jun. 15, 2023. |
U.S. Appl. No. 18/548,152, filed Aug. 28, 2023. |
U.S. Appl. No. 62/926,767, filed Oct. 28, 2019. |
U.S. Appl. No. 62/967,158, filed Jan. 26, 2020. |
U.S. Appl. No. 62/991,754, filed Mar. 19, 2020. |
U.S. Appl. No. 63/008,112, filed Apr. 10, 2020. |
U.S. Appl. No. 63/150,640, filed Feb. 18, 2021. |
U.S. Appl. No. 63/191,558, filed May 21, 2021. |
U.S. Appl. No. 63/192,289, filed May 24, 2021. |
U.S. Appl. No. 63/241,328, filed Sep. 7, 2021. |
U.S. Appl. No. 63/308,190, filed Feb. 9, 2022. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022, 72 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022, 99 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022, 106 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022, 115 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022, 117 pages. |
“AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page. |
“AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages. |
“AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages. |
“Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages. |
“GSA Price List”, Omni Medical, Apr. 2011, 2 pages. |
“How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene-fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages. |
“Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages. |
“Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages. |
Pieper , et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55. |
Vinas , “A Solution for an Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021, 3 pages. |
International Search Report and Written Opinion from International Application No. PCT/US2021/060993 mailed Mar. 18, 2022. |
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016. |
U.S. Appl. No. 17/754,736, filed Apr. 11, 2022. |
U.S. Appl. No. 62/923,279, filed Oct. 18, 2019. |
U.S. Appl. No. 63/094,646, filed Oct. 21, 2020. |
U.S. Appl. No. 63/230,897, filed Aug. 9, 2021. |
Action for U.S. Appl. No. 14/722,613 mailed Mar. 4, 2019. |
Action for U.S. Appl. No. 14/952,591 mailed Jun. 1, 2018. |
Action for U.S. Appl. No. 15/238,427 mailed Apr. 10, 2019. |
Action for U.S. Appl. No. 16/899,956 mailed Jul. 9, 2021. |
Action for U.S. Appl. No. 16/904,868 mailed Jul. 2, 2021. |
Advisory Action for U.S. Appl. No. 16/905,400 mailed Feb. 16, 2022. |
Advisory Action for U.S. Appl. No. 16/905,400 mailed Jun. 9, 2021. |
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 mailed Jan. 11, 2018. |
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 mailed Jul. 2, 2019. |
Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 mailed Mar. 17, 2021. |
Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 mailed Dec. 9, 2021. |
Final Office Action for U.S. Appl. No. 14/722,613 mailed on Nov. 29, 2018. |
Final Office Action for U.S. Appl. No. 14/947,759 mailed Apr. 8, 2016. |
Final Office Action for U.S. Appl. No. 14/952,591 mailed Feb. 23, 2018. |
Final Office Action for U.S. Appl. No. 14/952,591 mailed Nov. 1, 2019. |
Final Office Action for U.S. Appl. No. 14/952,591 mailed Nov. 27, 2020. |
Final Office Action for U.S. Appl. No. 15/171,968 mailed Feb. 14, 2020. |
Final Office Action for U.S. Appl. No. 15/171,968 mailed Mar. 19, 2019. |
Final Office Action for U.S. Appl. No. 15/221,106 mailed Jan. 23, 2019. |
Final Office Action for U.S. Appl. No. 15/238,427 mailed Jan. 2, 2019. |
Final Office Action for U.S. Appl. No. 15/260,103 mailed Feb. 14, 2019. |
Final Office Action for U.S. Appl. No. 15/612,325 mailed Sep. 17, 2020. |
Final Office Action for U.S. Appl. No. 16/452,145 mailed Mar. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/899,956 mailed Apr. 19, 2021. |
Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 10, 2022. |
Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 26, 2021. |
Final Office Action for U.S. Appl. No. 16/905,400 mailed Apr. 6, 2021. |
Final Office Action for U.S. Appl. No. 16/905,400 mailed Dec. 9, 2021. |
Final Office Action for U.S. Appl. No. 17/088,272 mailed May 25, 2021. |
Final Office Action for U.S. Appl. No. 29/624,661 mailed Feb. 18, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2016/049274 mailed Dec. 1, 2016. |
International Search Report and Written Opinion from International Application No. PCT/US2017/035625 mailed Aug. 15, 2017. |
International Search Report and Written Opinion from International Application No. PCT/US2017/043025 mailed Oct. 18, 2017. |
International Search Report and Written Opinion from International Application No. PCT/US2018/015968 mailed Apr. 6, 2018. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 mailed Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 mailed Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 mailed Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 mailed Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 mailed Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 mailed Sep. 26, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 mailed Aug. 30, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 mailed Jul. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033064 mailed Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033122 mailed Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 mailed Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 mailed Nov. 17, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 mailed Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 mailed Oct. 14, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 mailed Oct. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 mailed Nov. 12, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 mailed Dec. 1, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 mailed Dec. 15, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/061563 mailed Feb. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/065234 mailed Apr. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067451 mailed Mar. 25, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067454 mailed Mar. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067455 mailed Mar. 26, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015024 mailed May 18, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015787 mailed May 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/023001 mailed Jun. 21, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/024162 mailed Jul. 8, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027061 mailed Jul. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027104 mailed Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027314 mailed Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027422 mailed Aug. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027425 mailed Aug. 11, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027913 mailed Jul. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027917 mailed Aug. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/035181 mailed Sep. 16, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/043893 mailed Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/044699 mailed Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/045188 mailed Jan. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/047536 mailed Dec. 23, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048211 mailed Dec. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048661 mailed Feb. 14, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/056566 mailed Feb. 11, 2022. |
Issue Notification for U.S. Appl. No. 14/952,591 mailed Jul. 28, 2021. |
Issue Notification for U.S. Appl. No. 15/171,968 mailed Mar. 3, 2021. |
Issue Notification for U.S. Appl. No. 15/221,106 mailed Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/238,427 mailed Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/260,103 mailed Aug. 7, 2019. |
Issue Notification for U.S. Appl. No. 15/611,587 mailed Feb. 20, 2019. |
Issue Notification for U.S. Appl. No. 15/612,325 mailed Mar. 24, 2021. |
Issue Notification for U.S. Appl. No. 29/624,661 mailed Aug. 4, 2021. |
Non-Final Office Action for U.S. Appl. No. 14/592,591 mailed Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 14/722,613 mailed Jun. 13, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/947,759 mailed Mar. 17, 2016. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Aug. 1, 2017. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Mar. 21, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Sep. 28, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed May 11, 2020. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed Aug. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed Jun. 12, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/221,106 mailed Jun. 5, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/238,427 mailed Aug. 8, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/260,103 mailed Sep. 26, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 mailed Dec. 29, 2017. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 mailed Jul. 13, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/612,325 mailed Mar. 19, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/245,726 mailed Jan. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 mailed Dec. 8, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Sep. 28, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 mailed Sep. 28, 2021. |
Non-Final Office Action for U.S. Application No. 16/478, 180 mailed Oct. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 mailed Oct. 16, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 mailed Sep. 2, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Nov. 25, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Oct. 5, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Dec. 2, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Jul. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/088,272 mailed Jan. 25, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/330,657 mailed Aug. 11, 2021. |
Non-Final Office Action for U.S. Appl. No. 29/624,661 mailed Jul. 18, 2019. |
Non-Final Office Action for U.S. Appl. No. 29/694,002 mailed Jun. 24, 2020. |
Non-Final Office Action for U.S. Appl. No. 29/741,751 mailed Jan. 18, 2022. |
Notice of Allowance for U.S. Appl. No. 14/952,591 mailed Apr. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 14/952,591 mailed Jul. 8, 2021. |
Notice of Allowance for U.S. Appl. No. 15/171,968 mailed Feb. 16, 2021. |
Notice of Allowance for U.S. Appl. No. 15/171,968 mailed Nov. 6, 2020. |
Notice of Allowance for U.S. Appl. No. 15/221,106 mailed May 1, 2019. |
Notice of Allowance for U.S. Appl. No. 15/238,427 mailed May 23, 2019. |
Notice of Allowance for U.S. Appl. No. 15/260,103 mailed Jun. 7, 2019. |
Notice of Allowance for U.S. Appl. No. 15/611,587 mailed Dec. 21, 2018. |
Notice of Allowance for U.S. Appl. No. 15/612,325 mailed Feb. 19, 2021. |
Notice of Allowance for U.S. Appl. No. 15/612,325 mailed Jan. 21, 2021. |
Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Dec. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Aug. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Mar. 4, 2022. |
Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Nov. 24, 2021. |
Notice of Allowance for U.S. Appl. No. 17/330,657 mailed Mar. 16, 2022. |
Notice of Allowance for U.S. Appl. No. 17/330,657 mailed Nov. 26, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Apr. 28, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Jul. 10, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 mailed May 14, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Sep. 29, 2020. |
Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Apr. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Jan. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Oct. 16, 2020. |
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 mailed Mar. 3, 2021. |
Restriction Requirement for U.S. Appl. No. 16/433,773 mailed Dec. 7, 2021. |
Restriction Requirement for U.S. Appl. No. 16/478,180 mailed May 25, 2021. |
U.S. Appl. No. 14/625,469, filed Feb. 28, 2015. |
U.S. Appl. No. 14/947,759, filed Nov. 20, 2015. |
U.S. Appl. No. 14/952,591, filed Nov. 25, 2015. |
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016. |
U.S. Appl. No. 15/221,106, filed Jul. 27, 2016. |
U.S. Appl. No. 15/384,196, filed Dec. 19, 2016. |
U.S. Appl. No. 16/245,726, filed Jan. 11, 2019. |
U.S. Appl. No. 16/369,676, filed Mar. 29, 2019. |
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019. |
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019. |
U.S. Appl. No. 16/452,145, filed Jun. 25, 2019. |
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019. |
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019. |
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020. |
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020. |
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,554, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020. |
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020. |
U.S. Appl. No. 17/179,116, filed Feb. 18, 2021. |
U.S. Appl. No. 17/330,657, filed May 26, 2021. |
U.S. Appl. No. 17/378,015, filed Jul. 16, 2021. |
U.S. Appl. No. 17/394,055, filed Aug. 4, 2021. |
U.S. Appl. No. 17/412,864, filed Aug. 26, 2021. |
U.S. Appl. No. 17/444,825, filed Aug. 10, 2021. |
U.S. Appl. No. 17/446,256, filed Aug. 27, 2021. |
U.S. Appl. No. 17/446,654, filed Sep. 1, 2021. |
U.S. Appl. No. 17/447,123, filed Sep. 8, 2021. |
U.S. Appl. No. 17/450,864, filed Oct. 14, 2021. |
U.S. Appl. No. 17/451,345, filed Oct. 19, 2021. |
U.S. Appl. No. 17/451,354, filed Oct. 19, 2021. |
U.S. Appl. No. 17/453,260, filed Nov. 2, 2021. |
U.S. Appl. No. 17/453,560, filed Nov. 4, 2021. |
U.S. Appl. No. 17/461,036 mailed Aug. 30, 2021. |
U.S. Appl. No. 17/494,578, filed Oct. 5, 2021. |
U.S. Appl. No. 17/501,591, filed Oct. 14, 2021. |
U.S. Appl. No. 17/595,747, filed Nov. 23, 2021. |
U.S. Appl. No. 17/597,408, filed Jan. 5, 2022. |
U.S. Appl. No. 17/597,673, filed Jan. 18, 2022. |
U.S. Appl. No. 17/614,173, filed Nov. 24, 2021. |
U.S. Appl. No. 17/631,619, filed Jan. 31, 2022. |
U.S. Appl. No. 17/645,821, filed Dec. 23, 2021. |
U.S. Appl. No. 17/646,771, filed Jan. 3, 2022. |
U.S. Appl. No. 17/653,314, filed Mar. 3, 2022. |
U.S. Appl. No. 17/653,920, filed Mar. 8, 2022. |
U.S. Appl. No. 17/654,156, filed Mar. 9, 2022. |
U.S. Appl. No. 17/655,464, filed Mar. 18, 2022. |
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020. |
U.S. Appl. No. 61/955,537, filed Mar. 19, 2014. |
U.S. Appl. No. 62/082,279, filed Nov. 20, 2014. |
U.S. Appl. No. 62/084,078, filed Nov. 25, 2014. |
U.S. Appl. No. 62/414,963, filed Oct. 31, 2016. |
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017. |
U.S. Appl. No. 62/485,578, filed Apr. 14, 2017. |
U.S. Appl. No. 62/665,297, filed May 1, 2018. |
U.S. Appl. No. 62/665,302, filed May 1, 2018. |
U.S. Appl. No. 62/665,317, filed May 1, 2018. |
U.S. Appl. No. 62/665,321, filed May 1, 2018. |
U.S. Appl. No. 62/665,331, filed May 1, 2018. |
U.S. Appl. No. 62/665,335, filed May 1, 2018. |
U.S. Appl. No. 62/853,279, filed May 28, 2019. |
U.S. Appl. No. 62/853,889, filed May 29, 2019. |
U.S. Appl. No. 62/864,656, filed Jun. 21, 2019. |
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019. |
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019. |
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019. |
U.S. Appl. No. 62/877,558, filed Jul. 23, 2019. |
U.S. Appl. No. 62/883,172, filed Aug. 6, 2019. |
U.S. Appl. No. 62/889,149, filed Aug. 20, 2019. |
U.S. Appl. No. 62/935,337, filed Nov. 14, 2019. |
U.S. Appl. No. 62/938,447, filed Nov. 21, 2019. |
U.S. Appl. No. 62/949,187, filed Dec. 17, 2019. |
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020. |
U.S. Appl. No. 62/967,977, filed Jan. 30, 2020. |
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020. |
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020. |
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020. |
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020. |
U.S. Appl. No. 63/030,685, filed May 27, 2020. |
U.S. Appl. No. 63/033,310, filed Jun. 2, 2020. |
U.S. Appl. No. 63/047,374, filed Jul. 2, 2020. |
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020. |
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020. |
U.S. Appl. No. 63/064,126, filed Aug. 11, 2020. |
U.S. Appl. No. 63/067,542, filed Aug. 19, 2020. |
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020. |
U.S. Appl. No. 63/071,821, filed Aug. 28, 2020. |
U.S. Appl. No. 63/073,545, filed Sep. 2, 2020. |
U.S. Appl. No. 63/073,553, filed Sep. 2, 2020. |
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020. |
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020. |
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020. |
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020. |
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020. |
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020. |
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,539, filed Oct. 7, 2020. |
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020. |
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020. |
U.S. Appl. No. 63/109,084, filed Nov. 3, 2020. |
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020. |
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020. |
U.S. Appl. No. 63/124,271, filed Dec. 11, 2020. |
U.S. Appl. No. 63/133,892, filed Jan. 5, 2021. |
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021. |
U.S. Appl. No. 63/138,878, filed Jan. 19, 2021. |
U.S. Appl. No. 63/146,946, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021. |
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021. |
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021. |
U.S. Appl. No. 63/155,395, filed Mar. 2, 2021. |
U.S. Appl. No. 63/157,007, filed Mar. 5, 2021. |
U.S. Appl. No. 63/157,014, filed Mar. 5, 2021. |
U.S. Appl. No. 63/159,142, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,186, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,210, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,280, filed Mar. 10, 2021. |
U.S. Appl. No. 63/165,273, filed Mar. 24, 2021. |
U.S. Appl. No. 63/165,384, filed Mar. 24, 2021. |
U.S. Appl. No. 63/171,165, filed Apr. 6, 2021. |
U.S. Appl. No. 63/172,975, filed Apr. 9, 2021. |
U.S. Appl. No. 63/181,695, filed Apr. 29, 2021. |
U.S. Appl. No. 63/192,274, filed May 24, 2021. |
U.S. Appl. No. 63/193,235, filed May 26, 2021. |
U.S. Appl. No. 63/193,406, filed May 26, 2021. |
U.S. Appl. No. 63/193,891, filed May 27, 2021. |
U.S. Appl. No. 63/208,262, filed Jun. 8, 2021. |
U.S. Appl. No. 63/214,551, filed Jun. 24, 2021. |
U.S. Appl. No. 63/214,570, filed Jun. 24, 2021. |
U.S. Appl. No. 63/215,017, filed Jun. 25, 2021. |
U.S. Appl. No. 63/228,244, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,252, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,258, filed Aug. 2, 2021. |
U.S. Appl. No. 63/230,894, filed Aug. 9, 2021. |
U.S. Appl. No. 63/238,457, filed Aug. 30, 2021. |
U.S. Appl. No. 63/238,477, filed Aug. 30, 2021. |
U.S. Appl. No. 63/241,562, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,564, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,575, filed Sep. 8, 2021. |
U.S. Appl. No. 63/246,972, filed Sep. 22, 2021. |
U.S. Appl. No. 63/247,375, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,478, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,491, filed Sep. 23, 2021. |
U.S. Appl. No. 63/299,208, filed Jan. 13, 2022. |
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and 10,376,407, 292 pages. |
Plaintiff's Identification of Claim Terms and Proposed Constructions, 3 pages. |
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, 10,226,376, 10,390,989 and 10,376,407, 7 pages. |
Corrected Certificate of Service, 2020, 2 pages. |
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages. |
Declaration of Diane K. Newman Curriculum Vitae, 2020, pp. 1-199. |
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages. |
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Feb. 17, 2021, 39 pages. |
Memorandum Order, Feb. 2021, 14 pgs. |
Boehringer CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs. |
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Mar. 23, 2020, 6 pages. |
Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; and 10,390,989, May 29, 2020, 193 pages. |
Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019. |
Plaintiff's Opening Claim Construction Brief, Oct. 16, 2020, 26 pages. |
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page. |
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages. |
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, 8 pages. |
“AMXDmax In-Flight Bladder Relief”, Omni Medical; Omni Medical Systems, Inc., 2015. |
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, 2 pages. |
“External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages. |
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application”, https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub, Jul. 2016, 3 pages. |
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages. |
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages. |
“In Flight Bladder Relief”, Omni Medical, 14 pages. |
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages. |
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages. |
“Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages. |
“Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages. |
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, Aug. 30, 2017, 4 pages. |
“Underwear that absorbs your period”, Thinx!, 7 pages. |
“Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page. |
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages. |
“Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages. |
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, 2014, 4 pages. |
Ali , “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31. |
Autumn , et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579. |
Cañas , et al., “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces”, Acta Biomaterialia 8, 2012, pp. 282-288. |
Chaudhary , et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440. |
Dai , et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334. |
Espinoza-Ramirez , “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019. |
Hollister , “Female Urinary and Pouch and Male Urinary Pouch Brochure”, 2011, 1 page. |
Hollister , “Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device. |
Hollister , “Retracted Penis Pouch by Hollister”, Vitality Medical.com, 6 pages. |
Hwang , et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20. |
Jagota , et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292. |
Jeong , et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644. |
Jeong , et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346. |
Karp , et al., “Dry solution to a sticky problem”, Nature., 2011, pp. 42-43. |
Lee , et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5. |
Macaulay , et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, 2007, pp. 641-648. |
Newman , et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages. |
Newton , et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages. |
Parmar , “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick)”, Design Services, Nov. 10, 2014, 3 pages. |
Parness , et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232. |
Purewick , “Incontinence Relief for Women”, Presentation, Sep. 23, 2015, 7 pages. |
Pytlik , “Super Absorbent Polymers”, University of Buffalo. |
Sachtman , “New Relief for Pilots? It Depends”, Wired, 2008, 2 pages. |
Tsipenyuk , et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of The Royal Society—Interface, 2014, pp. 1-6. |
Advisory Action for U.S. Appl. No. 16/433,773 mailed Dec. 29, 2023. |
Advisory Action for U.S. Appl. No. 16/449,039 mailed Jan. 25, 2024. |
Advisory Action for U.S. Appl. No. 16/904,868 mailed Jan. 2, 2024. |
Advisory Action for U.S. Appl. No. 17/179,116 mailed Jan. 8, 2024. |
Advisory Action for U.S. Appl. No. 17/451,354 mailed Jan. 30, 2024. |
Advisory Action for U.S. Appl. No. 17/453,260 mailed Dec. 22, 2023. |
Advisory Action for U.S. Appl. No. 17/655,464 mailed Dec. 13, 2023. |
Advisory Action for U.S. Appl. No. 18/164,800 mailed Feb. 12, 2024. |
Communication of Notice of Opposition of European Application No. 17807547.9 mailed Jan. 5, 2024. |
Corrected Notice of Allowability for U.S. Appl. No. 17/326,980 mailed Feb. 8, 2024. |
Final Office Action for U.S. Appl. No. 16/452,258 mailed Dec. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/051,399 mailed Jan. 8, 2024. |
Final Office Action for U.S. Appl. No. 17/446,654 mailed Jan. 31, 2024. |
Final Office Action for U.S. Appl. No. 17/450,864 mailed Dec. 28, 2023. |
Final Office Action for U.S. Appl. No. 17/646,771 mailed Dec. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/661,090 mailed Dec. 11, 2023. |
Final Office Action for U.S. Appl. No. 17/663,330 mailed Dec. 12, 2023. |
Final Office Action for U.S. Appl. No. 17/664,487 mailed Jan. 4, 2024. |
Final Office Action for U.S. Appl. No. 18/139,523 mailed Dec. 22, 2023. |
Final Office Action for U.S. Appl. No. 18/140,751 mailed Jan. 17, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/024805 mailed Dec. 14, 2023. |
Issue Notification for U.S. Appl. No. 17/663,046 mailed Dec. 20, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,585 mailed Jan. 8, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/051,600 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/446,256 mailed Feb. 13, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/447,123 mailed Jan. 24, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/448,811 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/653,137 mailed Jan. 18, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/664,914 mailed Jan. 31, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/134,857 mailed Jan. 25, 2024. |
Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 7, 2024. |
Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Jan. 29, 2024. |
Notice of Allowance for U.S. Appl. No. 17/453,560 mailed Jan. 31, 2024. |
Submission in Opposition Proceedings for European Application No. 17807547.9 filed Jan. 10, 2024. |
Supplemental Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Feb. 14, 2024. |
U.S. Appl. No. 18/294,370, filed Feb. 1, 2024. |
U.S. Appl. No. 18/294,403, filed Feb. 1, 2024. |
U.S. Appl. No. 18/415,080, filed Jan. 17, 2024. |
U.S. Appl. No. 18/426,795, filed Jan. 30, 2024. |
U.S. Appl. No. 18/569,711, filed Dec. 13, 2023. |
U.S. Appl. No. 18/569,778, filed Dec. 13, 2023. |
U.S. Appl. No. 18/681,987, filed Feb. 7, 2024. |
U.S. Appl. No. 18/682,006, filed Feb. 7, 2024. |
U.S. Appl. No. 63/608,553, filed Dec. 11, 2023. |
Wikipedia Article , “Zylinder (Geometrie)”, https://de.wikipedia.org/w/index.php?title=Zylinder (Geometrie) &oldid=154862081, version of Jun. 1, 2016, 7 pages. |
Advisory Action for U.S. Appl. No. 16/478,180 mailed Sep. 7, 2023. |
Advisory Action for U.S. Appl. No. 17/051,550 mailed Sep. 8, 2023. |
Advisory Action for U.S. Appl. No. 17/051,585 mailed Oct. 17, 2023. |
Advisory Action for U.S. Appl. No. 17/446,2356 mailed Dec. 8, 2023. |
Advisory Action for U.S. Appl. No. 17/448,811 mailed Nov. 15, 2023. |
Advisory Action for U.S. Appl. No. 17/451,345 mailed Oct. 20, 2023. |
Advisory Action for U.S. Appl. No. 17/653,137 mailed Dec. 1, 2023. |
Corrected Notice of Allowance for U.S. Appl. No. 16/369,676 mailed Dec. 7, 2023. |
Final Office Action for U.S. Appl. No. 16/369,676 mailed Aug. 31, 2023. |
Final Office Action for U.S. Appl. No. 16/433,773 mailed Oct. 10, 2023. |
Final Office Action for U.S. Appl. No. 16/449,039 mailed Nov. 21, 2023. |
Final Office Action for U.S. Appl. No. 16/904,868 mailed Nov. 2, 2023. |
Final Office Action for U.S. Appl. No. 17/179,116 mailed Oct. 31, 2023. |
Final Office Action for U.S. Appl. No. 17/446,256 mailed Sep. 19, 2023. |
Final Office Action for U.S. Appl. No. 17/451,354 mailed Oct. 30, 2023. |
Final Office Action for U.S. Appl. No. 17/453,260 mailed Oct. 5, 2023. |
Final Office Action for U.S. Appl. No. 17/501,591 mailed Nov. 14, 2023. |
Final Office Action for U.S. Appl. No. 17/653,137 mailed Sep. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/655,464 mailed Sep. 1, 2023. |
Final Office Action for U.S. Appl. No. 18/164,800 mailed Dec. 6, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/018474 mailed Sep. 11, 2023. |
Issue Notification for U.S. Appl. No. 16/245,726 mailed Oct. 18, 2023. |
Issue Notification for U.S. Appl. No. 17/461,036 mailed Oct. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Nov. 2, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Nov. 7, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,550 mailed Oct. 24, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/444,792 mailed Nov. 17, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,654 mailed Sep. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/453,560 mailed Oct. 16, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/645,821 mailed Oct. 25, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/808,354 mailed Nov. 28, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/140,163 mailed Nov. 9, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/140,751 mailed Sep. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/198,464 mailed Dec. 7, 2023. |
Notice of Allowance for U.S. Appl. No. 16/369,676 mailed Nov. 14, 2023. |
Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Oct. 18, 2023. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Nov. 15, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Nov. 6, 2023. |
Restriction Requirement for U.S. Appl. No. 17/051,600 mailed Sep. 21, 2023. |
Restriction Requirement for U.S. Appl. No. 17/645,821 mailed Jul. 12, 2023. |
Restriction Requirement for U.S. Appl. No. 18/134,857 mailed Oct. 23, 2023. |
U.S. Appl. No. 17/451,719, filed Oct. 19, 2021. |
U.S. Appl. No. 18/373,424, filed Sep. 27, 2023. |
U.S. Appl. No. 18/376,274, filed Oct. 3, 2023. |
U.S. Appl. No. 18/389,009, filed Nov. 13, 2023. |
U.S. Appl. No. 18/549,387, filed Sep. 7, 2023. |
U.S. Appl. No. 18/549,658, filed Sep. 8, 2023. |
U.S. Appl. No. 18/553,625, filed Oct. 2, 2023. |
U.S. Appl. No. 18/556,945, filed Oct. 24, 2023. |
U.S. Appl. No. 18/558,502, filed Nov. 1, 2023. |
U.S. Appl. No. 18/562,626, filed Nov. 20, 2023. |
U.S. Appl. No. 18/563,672, filed Nov. 22, 2023. |
U.S. Appl. No. 63/596,012, filed Nov. 3, 2023. |
Merriam-Webster Dictionary, “Embed Definition & Meaning”, https://www.merriam-webster.com/dictionary/embed last accessed Aug. 3, 2023, 2003. |
Advisory Action for U.S. Appl. No. 17/450,864 mailed on Mar. 21, 2024. |
Advisory Action for U.S. Appl. No. 17/501,591 mailed Feb. 22, 2024. |
Advisory Action for U.S. Appl. No. 17/646,771 mailed Feb. 29, 2024. |
Advisory Action for U.S. Appl. No. 17/661,090 mailed Feb. 26, 2024. |
Advisory Action for U.S. Appl. No. 17/663,330 mailed Feb. 27, 2024. |
Advisory Action for U.S. Appl. No. 17/664,487 mailed Mar. 13, 2024. |
Final Office Action for U.S. Appl. No. 16/478,180 mailed Feb. 28, 2024. |
Final Office Action for U.S. Appl. No. 17/444,792, filed Apr. 3, 2024. |
Final Office Action for U.S. Appl. No. 17/645,821 mailed Apr. 3, 2024. |
Final Office Action for U.S. Appl. No. 18/140,163 mailed Mar. 27, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/025192 mailed Feb. 7, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/025939 mailed Feb. 7, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/031433 mailed Mar. 4, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/031740 mailed Mar. 4, 2024. |
Issue Notification for U.S. Appl. No. 17/051,550 mailed Mar. 13, 2024. |
Issue Notification for U.S. Appl. No. 17/051,554 mailed Mar. 6, 2024. |
Issue Notification for U.S. Appl. No. 18/299,788 mailed Feb. 21, 2024. |
Non-Final Office Action for U.S. Appl. No. 16/369,676 mailed Feb. 29, 2024. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Feb. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 12, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/179,116 mailed Feb. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/597,673 mailed Mar. 20, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/653,920 mailed Mar. 15, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/655,464 mailed Mar. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/003,029 mailed Mar. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/164,800 mailed Mar. 22, 2024. |
Notice of Allowance for U.S. Appl. No. 16/449,039 mailed Mar. 28, 2024. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Mar. 6, 2024. |
Restriction Requirement for U.S. Appl. No. 17/667,097 mailed Mar. 20, 2024. |
Supplemental Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 21, 2024. |
U.S. Appl. No. 17/444,792, filed Aug. 10, 2021. |
U.S. Appl. No. 18/249,577, filed Oct. 19, 2021. |
U.S. Appl. No. 18/584,002, filed Feb. 22, 2024. |
U.S. Appl. No. 18/610,523, filed Mar. 20, 2024. |
U.S. Appl. No. 18/687,117, filed Feb. 27, 2024. |
U.S. Appl. No. 18/688,023, filed Feb. 29, 2024. |
U.S. Appl. No. 18/693,638, filed Mar. 20, 2024. |
U.S. Appl. No. 18/694,090, filed Mar. 21, 2024. |
U.S. Appl. No. 63/561,893, filed Dec. 11, 2023. |
Wikipedia Article , “Decibel”, https://web.archive.org/web/2020041521917/https://en.wikipedia/org/wiki/Decibel last accessed Mar. 11, 2024, 21 pages. |
Wikipedia Article , “Fiberglass”, https://web.archive.org.web/20200309194847/https://en.wikipedia.org/wiki/Fiberglass last accessed Mar. 11, 2024, 13 pages. |
Advisory Action for U.S. Appl. No. 16/452,258 mailed Apr. 8, 2024. |
Advisory Action for U.S. Appl. No. 17/446,654 mailed Apr. 15, 2024. |
Advisory Action for U.S. Appl. No. 18/139,523 mailed Apr. 24, 2024. |
Advisory Action for U.S. Appl. No. 18/140,751 mailed Apr. 24, 2024. |
Final Office Action for U.S. Appl. No. 17/451,345 mailed Apr. 18, 2024. |
Final Office Action for U.S. Appl. No. 17/808,354 mailed Apr. 10, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/030373 mailed Mar. 13, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/451,354 mailed Apr. 4, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/646,771 mailed Apr. 24, 2024. |
Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Apr. 5, 2024. |
Notice of Allowance for U.S. Appl. No. 17/453,260 mailed Apr. 8, 2024. |
Notice of Allowance for U.S. Appl. No. 18/198,464 mailed Apr. 17, 2024. |
Number | Date | Country | |
---|---|---|---|
20220313474 A1 | Oct 2022 | US |
Number | Date | Country | |
---|---|---|---|
63171165 | Apr 2021 | US |